Drug Description in Trials / DrugBank / KEGG DRUG /

Search results

No.	薬物名（臨床試験情報から抽出）	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY	指定難病告示番号
1	( L ) ASCORBATO DI CALCIO	1件: Calcium	-	-	-	2件: 96, 97
2	(-)-3-(4-Aminophenyl)-2-methoxypropionic acid	-	-	-	-	1件: 97
3	(R)-3-(1-oxo-propoxy)-4-(N,N,N-trimethyl amonium chloride)-butanoic acid	2件: Butyric Acid, Chloride ion	-	-	-	1件: 97
4	(S)-(-)-3-(4-Aminophenyl)-2-methoxypropionic Acid	-	-	-	-	1件: 97
5	(S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5- yl)-2-isopropoxybenzonitrile hydrochloride	-	-	-	-	1件: 97
6	(S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxyben	-	-	-	-	1件: 97
7	(S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile hydrochloride	-	-	-	-	1件: 97
8	* D.3.4 Solution for infusion in pre-filled syringe	-	-	-	-	1件: 97
9	* D.3.4 Solution for injection in pre-filled syringe	-	-	-	-	1件: 97
10	* D.3.4 Solution for injection/infusion in pre-filled syringe	-	-	-	-	1件: 97
11	-aminosalicylic acid	1件: Aminosalicylic acid	1件: D00162	-	-	2件: 96, 97
12	0.25 mg RPC103	-	-	-	-	1件: 97
13	0.25 mg RPC1063	-	-	-	-	3件: 13, 96, 97
14	0.25mg RPC103	-	-	-	-	1件: 97
15	0.25mg RPC1063	-	-	-	-	2件: 13, 97
16	0.5 mg RPC1063	-	-	-	-	2件: 13, 97
17	1 mg RPC1063	-	-	-	-	2件: 13, 97
18	1 Serving of broccoli sprouts	1件: Broccoli	-	-	-	1件: 97
19	1.0 mg RPC103	-	-	-	-	1件: 97
20	1.0 mg RPC1063	-	-	-	-	1件: 97
21	1.Remicade	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
22	10 mg Natura-alpha capsule	-	-	-	-	1件: 97
23	100	-	-	-	-	2件: 6, 97
24	100 mg	-	-	-	-	1件: 97
25	14C]-RPC1063 Solution (0.1 mg/mL) for Oral Administration	-	-	-	-	3件: 13, 96, 97
26	150 mg Induction/Chronic	-	-	-	-	1件: 97
27	1500mg mesalazine pellets	1件: Mesalazine	1件: D00377	-	-	1件: 97
28	15N2-tofacitinib	1件: Tofacitinib	1件: D09970	4件: JAK1, JAK2, JAK3, TYK2 💬	37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬	1件: 97
29	2 x 10 mg Natura-alpha capsules	-	-	-	-	1件: 97
30	2'-Fucosyllactose	-	-	-	-	2件: 96, 97
31	2-Hydroxybenzoic acid	1件: Salicylic acid	1件: D00097	-	-	1件: 97
32	20 mg	-	-	-	-	1件: 97
33	225mg SHP647 (PF-00547659)	-	-	-	-	1件: 97
34	23-valent polysaccharide pneumococcal vaccine (Pneumovax TM)	-	-	-	-	2件: 96, 97
35	25 mg Ontamalimab	1件: Ontamalimab	-	-	-	2件: 96, 97
36	250mg mesalazine pellets	1件: Mesalazine	1件: D00377	-	-	1件: 97
37	2L polyethylene glycol/ascorbic acid	2件: Ascorbic acid, Polyethylene glycol	2件: D00018 , D03370	-	-	1件: 97
38	3 Servings of broccoli sprouts	1件: Broccoli	-	-	-	1件: 97
39	3-hydroxy-2-methyl-4H-pyrane-4-one iron (III) complex (3:1), Ferric (3-hydroxy-2-methyl-4-pyrone), Tris-maltol-iron (III), Tri=maltol-iron (III)	1件: Tromethamine	1件: D00396	-	-	2件: 96, 97
40	331731-18-1	-	-	-	-	4件: 46, 96, 97, 271
41	40 mg MSB11022	-	-	-	-	5件: 46, 96, 97, 107, 271
42	42942019	-	-	-	-	4件: 46, 96, 97, 271
43	450 mg Induction/Chronic	-	-	-	-	1件: 97
44	5 ASA, enemas, suppositories, corticosteroids	-	-	-	-	1件: 97
45	5-amino salicylic acid	1件: Salicylic acid	1件: D00097	-	-	1件: 97
46	5-amino salicylic acid (5-ASA)	2件: Mesalazine, Salicylic acid	2件: D00097 , D00377	-	-	1件: 97
47	5-amino-2-hydroxybenzoic acid	1件: Salicylic acid	1件: D00097	-	-	1件: 97
48	5-Aminosalicyclic acid	-	-	-	-	1件: 97
49	5-aminosalicylate (Pentasa, Ferring)	-	-	-	-	2件: 96, 97
50	5-Aminosalicylic acid	2件: Aminosalicylic acid, Mesalazine	2件: D00162 , D00377	-	-	2件: 96, 97
51	5-Aminosalicylic acid (5-ASA)	2件: Aminosalicylic acid, Mesalazine	2件: D00162 , D00377	-	-	1件: 97
52	5-ASA	1件: Mesalazine	1件: D00377	-	-	1件: 97
53	5-ASA (5-Aminosalicylate)	1件: Mesalazine	1件: D00377	-	-	1件: 97
54	5-ASA MMx	1件: Mesalazine	1件: D00377	-	-	1件: 97
55	5-HTP	-	-	-	-	2件: 96, 97
56	50 mg	-	-	-	-	1件: 97
57	50 mg Induction/Chronic	-	-	-	-	1件: 97
58	500mg mesalazine pellets	1件: Mesalazine	1件: D00377	-	-	1件: 97
59	549-0261/F02-01	-	-	-	-	2件: 96, 97
60	6 Mercaptopurine	1件: Mercaptopurine	2件: D00161 , D04931	1件: HPRT1 💬	4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬	2件: 96, 97
61	6-[2-(3,4-diethoxyphenyl)thiazol-4-yl] pyridine-2-carboxylic acid	-	-	-	-	1件: 97
62	6-Mercaptopurine	1件: Mercaptopurine	2件: D00161 , D04931	1件: HPRT1 💬	4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬	3件: 96, 97, 164
63	6-MP	1件: Mercaptopurine	2件: D00161 , D04931	1件: HPRT1 💬	4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬	2件: 96, 97
64	75 mg Ontamalimab	1件: Ontamalimab	-	-	-	2件: 96, 97
65	750mg mesalazine pellets	1件: Mesalazine	1件: D00377	-	-	1件: 97
66	75mg SHP647 (PF-00547659)	-	-	-	-	1件: 97
67	90 mg hydrocortisone acetate suppository with Sephure suppository applicator	3件: Acetate, Hydrocortisone, Hydrocortisone acetate	2件: D00088 , D00165	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
68	90 mg idrocortisone acetato in supposta con appli	-	-	-	-	1件: 97
69	90 mg idrocortisone acetato in supposta con applicatore per supposte Sephure	-	-	-	-	1件: 97
70	[124I]IB PF 06687234	-	-	-	-	2件: 96, 97
71	[18F]FSPG	-	-	-	-	2件: 96, 97
72	A multistrain probiotic product (DSF)	-	-	-	-	1件: 97
73	A07DA03	-	-	-	-	1件: 97
74	A: 1 dosis	-	-	-	-	1件: 97
75	AB (antibiotics)	-	-	-	-	1件: 97
76	Abalimumab	-	-	-	-	1件: 97
77	Abatacept	1件: Abatacept	1件: D03203	2件: CD80, CD86 💬	13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬	26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300
78	Abatacept (ABA)	1件: Abatacept	1件: D03203	2件: CD80, CD86 💬	13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬	1件: 97
79	ABBV-006	-	-	-	-	1件: 97
80	ABBV-066	-	-	-	-	2件: 96, 97
81	ABBV-323	-	-	-	-	2件: 53, 97
82	ABBV-323 Dose A	-	-	-	-	1件: 97
83	ABBV-323 Dose B	-	-	-	-	1件: 97
84	ABBV-668	-	-	-	-	1件: 97
85	AbGn-168H	-	-	-	-	1件: 97
86	ABI-M201	-	-	-	-	1件: 97
87	Abrilumab	1件: Abrilumab	1件: D10540	2件: ITGA4, ITGB7 💬	15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬	2件: 96, 97
88	ABT-494	-	-	-	-	7件: 41, 46, 49, 96, 97, 107, 271
89	ABT-Humira	1件: Adalimumab	1件: D02597	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	2件: 46, 97
90	ABX464	-	-	-	-	3件: 46, 96, 97
91	ABX464 100mg	-	-	-	-	2件: 46, 97
92	ABX464 25mg	-	-	-	-	1件: 97
93	ABX464 50mg	-	-	-	-	2件: 46, 97
94	Accelerated 1 hour-infusion	-	-	-	-	2件: 96, 97
95	Accelerated 30 minutes-infusion	-	-	-	-	2件: 96, 97
96	Acetate	1件: Acetate	-	-	-	41件: 1, 2, 6, 10, 13, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 171, 206, 222, 224, 225, 227, 235, 251, 265, 288, 298, 299
97	ACETATO DI AMMONIO	-	-	-	-	1件: 97
98	Acetic acid	1件: Acetic acid	1件: D00010	-	-	1件: 97
99	Acidophilus	1件: Lactobacillus acidophilus	1件: D04349	-	-	2件: 6, 97
100	Adalimumab	1件: Adalimumab	1件: D02597	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	17件: 19, 37, 40, 41, 46, 56, 84, 96, 97, 107, 160, 164, 222, 226, 269, 270, 271
101	Adalimumab 40mg	1件: Adalimumab	1件: D02597	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
102	Adipate	1件: Iron (III) oxide adipate	-	-	-	2件: 97, 228
103	Adipose derived, autologous mesenchymal stem cells	-	-	-	-	1件: 97
104	Adipose tissue-derived mesenchymal stem cells	-	-	-	-	1件: 97
105	Adipose-cord mesenchymal stromal cells (A-MSCs)	1件: Human Umbilical Cord Mesenchymal Stem Cells	-	-	-	1件: 97
106	AEB071	-	-	-	-	1件: 97
107	AEB071A	-	-	-	-	1件: 97
108	AG011	-	-	-	-	1件: 97
109	AG011 - Capsules	-	-	-	-	1件: 97
110	AG011 - Enema	-	-	-	-	1件: 97
111	Air	-	-	-	-	3件: 85, 97, 193
112	AJG501	-	-	-	-	1件: 97
113	AJG511	-	-	-	-	1件: 97
114	AJM300	-	-	-	-	1件: 97
115	AL	-	-	-	-	11件: 5, 6, 7, 13, 28, 51, 67, 86, 97, 114, 127
116	ALDESLEUKIN	1件: Aldesleukin	1件: D00748	3件: IL2RA, IL2RB, IL2RG 💬	14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬	4件: 49, 65, 96, 97
117	Algin	1件: Alginic acid	1件: D02324	-	-	1件: 97
118	Alicaforsen	1件: Alicaforsen	-	-	-	2件: 96, 97
119	Alkaline Phosphatase	1件: Alkaline Phosphatase	-	-	-	4件: 46, 93, 97, 172
120	Allogeneic adipose tissue-derived mesenchymal stem cells	-	-	-	-	1件: 97
121	Allopurinol	1件: Allopurinol	1件: D00224	1件: XDH 💬	6件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬	7件: 6, 46, 57, 60, 66, 96, 97
122	AloASC	-	-	-	-	1件: 97
123	Aloe	1件: Aloe vera leaf	-	-	-	2件: 97, 226
124	Aloe Barbadensis Miller	1件: Aloe vera leaf	-	-	-	1件: 97
125	Aloe vera	1件: Aloe vera leaf	-	-	-	2件: 97, 226
126	Aloe vera gel	1件: Aloe vera leaf	-	-	-	1件: 97
127	Also referred to as 'MEDI2070'	-	-	-	-	2件: 96, 97
128	Also referred to as MEDI2070	-	-	-	-	2件: 96, 97
129	ALTH12-1:4	-	-	-	-	1件: 97
130	ALTH12-2:4	-	-	-	-	1件: 97
131	AMG 181	-	-	-	-	2件: 96, 97
132	AMG 592	-	-	-	-	3件: 46, 49, 97
133	AMG181	-	-	-	-	1件: 97
134	Amgevita	1件: Adalimumab	1件: D02597	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	2件: 96, 97
135	AMGEVITA (Adalimumab biosimilar )	1件: Adalimumab	1件: D02597	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	2件: 96, 97
136	Amgevita 40 mg Injektionslösung im Fertigpen	1件: Adalimumab	1件: D02597	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	2件: 96, 97
137	Amgevita 40 mg Injektionslösung in einer Fertigspritze	1件: Adalimumab	1件: D02597	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	2件: 96, 97
138	Amgevita 40Mg Solution for Injection	-	-	-	-	2件: 96, 97
139	AMGEVITA®	1件: Adalimumab	1件: D02597	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	2件: 96, 97
140	AMINOSALICYLIC ACID	1件: Aminosalicylic acid	1件: D00162	-	-	2件: 96, 97
141	Amiselimod	1件: Amiselimod	1件: D10905	5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬	3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬	1件: 97
142	Amitriptyline	1件: Amitriptyline	1件: D07448	2件: SLC6A2, SLC6A4 💬	2件: Serotonergic synapse, Synaptic vesicle cycle 💬	4件: 78, 97, 226, 299
143	Amitriptyline hydrochloride	1件: Amitriptyline	1件: D07448	2件: SLC6A2, SLC6A4 💬	2件: Serotonergic synapse, Synaptic vesicle cycle 💬	1件: 97
144	Amoxicillin	1件: Amoxicillin	2件: D00229 , D07452	-	-	7件: 6, 46, 63, 96, 97, 222, 299
145	Amoxicillin and doxycyclin	2件: Amoxicillin, Doxycycline	4件: D00229 , D00307 , D07452 , D07876	-	-	1件: 97
146	Amoxicillin, metronidazole and doxycycline	3件: Amoxicillin, Doxycycline, Metronidazole	5件: D00229 , D00307 , D00409 , D07452 , D07876	-	-	1件: 97
147	AMT	-	-	-	-	4件: 8, 46, 97, 321
148	AMT-101	-	-	-	-	2件: 46, 97
149	AMT-101 (oral)	-	-	-	-	1件: 97
150	Anakinra	1件: Anakinra	1件: D02934	2件: IL1R1, IL1R2 💬	15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬	16件: 2, 13, 15, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299
151	AND (Andrographolide)	1件: Andrographolide	-	-	-	1件: 97
152	Andecaliximab	-	-	-	-	4件: 46, 96, 97, 299
153	AndoSan	-	-	-	-	2件: 96, 97
154	ANDROGRAPHIS PANICULATA	-	-	-	-	1件: 97
155	ANDROGRAPHIS PANICULATA (ethanol extract)	1件: Ethanol	1件: D06542	-	-	1件: 97
156	Andrographolide	1件: Andrographolide	-	-	-	1件: 97
157	Anrukinzumab	1件: Anrukinzumab	1件: D08857	1件: IL13 💬	8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬	1件: 97
158	Anti Beta7	-	-	-	-	1件: 97
159	Anti CD3 monoclonal antibody	-	-	-	-	1件: 97
160	Anti TNF therapy including infliximab	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	2件: 96, 97
161	Anti-CD3	1件: Muromonab	-	-	-	2件: 96, 97
162	Anti-CD3 Monoclonal antibody	1件: Muromonab	-	-	-	2件: 96, 97
163	Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Huma	-	-	-	-	2件: 96, 97
164	Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human	-	-	-	-	2件: 96, 97
165	Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody	-	-	-	-	2件: 96, 97
166	Anti-IP-10 Antibody	-	-	-	-	1件: 97
167	Anti-MAdCAM antibody	-	-	-	-	2件: 96, 97
168	Anti-TL1A	-	-	-	-	1件: 97
169	Anti-TNF discontinuation: Physiological saline solution	-	-	-	-	2件: 96, 97
170	Anti-TNF Drug	-	-	-	-	2件: 96, 97
171	Anti-TNF therapy	-	-	-	-	3件: 46, 96, 97
172	Anti-TNF: Infliximab (Infusion)	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	2件: 96, 97
173	Anti-TNF:Adalimumab (Subcutaneus)	1件: Adalimumab	1件: D02597	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	2件: 96, 97
174	Antibiotic cocktail	-	-	-	-	1件: 97
175	AODG (Apigenin-7-O-glucuronide)	1件: Apigenin	-	-	-	1件: 97
176	APD334	-	-	-	-	5件: 93, 96, 97, 98, 269
177	APD334 L-arginine	1件: Arginine	1件: D02982	-	-	1件: 97
178	Apigenin	1件: Apigenin	-	-	-	2件: 6, 97
179	APL-1401	-	-	-	-	1件: 97
180	Apremilast	1件: Apremilast	1件: D08860	4件: PDE4A, PDE4B, PDE4C, PDE4D 💬	5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬	7件: 46, 50, 56, 97, 107, 162, 271
181	Apriso 0.375G ER CAP	-	-	-	-	1件: 97
182	APRISO 375 mg extended-release capsules	1件: Manganese citrate	-	-	-	1件: 97
183	APVO210	-	-	-	-	1件: 97
184	Aquamin	-	-	-	-	1件: 97
185	Aquamin®	-	-	-	-	1件: 97
186	AR401959 L-arginine	2件: Arginine, L-arginine	1件: D02982	-	-	3件: 96, 97, 98
187	Arginine	1件: Arginine	1件: D02982	-	-	11件: 46, 58, 67, 78, 96, 97, 98, 113, 210, 251, 299
188	ASA	-	-	-	-	3件: 13, 97, 251
189	ASACOL	-	-	-	-	1件: 97
190	Asacol (mesalamine)	1件: Mesalazine	1件: D00377	-	-	1件: 97
191	Asacol (mesalamine) Delayed-release Tablets	1件: Mesalazine	1件: D00377	-	-	1件: 97
192	Asacol 400 mg	-	-	-	-	1件: 97
193	Asacol 400 mg (mesalamine)	1件: Mesalazine	1件: D00377	-	-	1件: 97
194	Asacol 400 mg tablet	1件: Mesalazine	1件: D00377	-	-	1件: 97
195	Asacol 400mg tablet	1件: Mesalazine	1件: D00377	-	-	1件: 97
196	Asacol 800 mg (mesalamine)	1件: Mesalazine	1件: D00377	-	-	1件: 97
197	Asacol 800 mg tablet	1件: Mesalazine	1件: D00377	-	-	1件: 97
198	Asacol 800mg tablet	1件: Mesalazine	1件: D00377	-	-	1件: 97
199	Asacol Delayed Release Tablets	2件: Manganese citrate, Mesalazine	1件: D00377	-	-	1件: 97
200	Asacol Delayed-Release Tablets	2件: Manganese citrate, Mesalazine	1件: D00377	-	-	1件: 97
201	Asacol tablet	1件: Mesalazine	1件: D00377	-	-	1件: 97
202	Asacol®	1件: Mesalazine	1件: D00377	-	-	1件: 97
203	Asacol® 400 mg	-	-	-	-	1件: 97
204	ASC	-	-	-	-	4件: 36, 51, 96, 97
205	Ascorbic acid	1件: Ascorbic acid	1件: D00018	-	-	4件: 10, 97, 206, 298
206	ASP015K	-	-	-	-	2件: 46, 97
207	ASP3291	-	-	-	-	1件: 97
208	Aspergillus oryzae	1件: Aspergillus oryzae	-	-	-	1件: 97
209	AST-120	-	-	-	-	2件: 96, 97
210	ATL-2502	1件: ATL-2502	-	-	-	1件: 97
211	Atorvastatin	1件: Atorvastatin	1件: D07474	1件: HMGCR 💬	4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬	19件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299
212	Atorvastatin 80mg	1件: Atorvastatin	1件: D07474	1件: HMGCR 💬	4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬	1件: 97
213	Atorvastatin Calcium	2件: Atorvastatin, Calcium	1件: D07474	1件: HMGCR 💬	4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬	2件: 97, 265
214	AVONEX	1件: Interferon beta-1a	1件: D04554	2件: IFNAR1, IFNAR2 💬	18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬	2件: 13, 97
215	AVX 470	-	-	-	-	1件: 97
216	AZA	-	-	-	-	4件: 11, 40, 96, 97
217	AZAFOR - 50 MG COMPRESSE RIVESTITE CON FILM 50 COMPRESSE IN BLISTER PVC/PVDC/AL	-	-	-	-	1件: 97
218	AZAFOR 50mg	-	-	-	-	1件: 97
219	Azathioprine	1件: Azathioprine	1件: D00238	-	-	21件: 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162
220	Azathioprine (AZA)	1件: Azathioprine	1件: D00238	-	-	3件: 13, 19, 97
221	Azathioprine (AZA) or 6-mercaptopurine (6-MP)	2件: Azathioprine, Mercaptopurine	3件: D00161 , D00238 , D04931	1件: HPRT1 💬	4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬	2件: 96, 97
222	Azathioprine (Imuran) 50 mg Overencapsulated Tablet	1件: Azathioprine	1件: D00238	-	-	1件: 97
223	Azathioprine and Allopurinol	2件: Allopurinol, Azathioprine	2件: D00224 , D00238	1件: XDH 💬	6件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬	1件: 97
224	AZATHIOPRINE BP	1件: Azathioprine	1件: D00238	-	-	1件: 97
225	Azathioprine or 6-mercaptopurine	2件: Azathioprine, Mercaptopurine	3件: D00161 , D00238 , D04931	1件: HPRT1 💬	4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬	2件: 96, 97
226	Azatioprina	1件: Azathioprine	1件: D00238	-	-	3件: 13, 96, 97
227	B2-ASmedic	-	-	-	-	1件: 97
228	B: 2 dosis	-	-	-	-	1件: 97
229	Bacteriotherapy	-	-	-	-	2件: 96, 97
230	Balsalazide	1件: Balsalazide	1件: D07488	-	-	1件: 97
231	Balsalazide Disodium	1件: Balsalazide	1件: D07488	-	-	1件: 97
232	Baminercept	1件: Baminercept	1件: D08866	1件: LTB 💬	3件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis 💬	4件: 13, 46, 53, 97
233	Bascial prescription plus or minus herbs depend on symptoms	-	-	-	-	1件: 97
234	Basiliximab	1件: Basiliximab	1件: D03058	1件: IL2RA 💬	11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬	5件: 2, 50, 97, 222, 228
235	BBT-401-1S	-	-	-	-	1件: 97
236	BBT-401-1S, Multiple doses	-	-	-	-	1件: 97
237	BBT-401-1S, Single dose	-	-	-	-	1件: 97
238	Beclometasone	-	-	-	-	1件: 97
239	Beclometasone dipropionate	1件: Beclomethasone dipropionate	1件: D00689	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	2件: 85, 97
240	Beclomethasone dipropionate	1件: Beclomethasone dipropionate	1件: D00689	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	2件: 97, 98
241	Beclomethasone diproprionate	-	-	-	-	1件: 97
242	Berberine	1件: Berberine	-	-	-	2件: 97, 265
243	Berberine Chloride	2件: Berberine, Chloride ion	-	-	-	1件: 97
244	Bertilimumab	-	-	-	-	2件: 97, 162
245	Beta-1,3/1,6-D-Glucan	-	-	-	-	1件: 97
246	Bezlotoxumab	1件: Bezlotoxumab	1件: D10453	-	-	2件: 96, 97
247	BG9418 (interferon beta-1a)	2件: Human interferon beta, Interferon beta-1a	1件: D04554	2件: IFNAR1, IFNAR2 💬	18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬	2件: 13, 97
248	BG9924	-	-	-	-	2件: 46, 97
249	BGP-014	-	-	-	-	1件: 97
250	BGP-014 Capsules	-	-	-	-	1件: 97
251	BI 655130	-	-	-	-	3件: 37, 96, 97
252	BIAP	-	-	-	-	2件: 46, 97
253	Bifidobacterium breve	1件: Bifidobacterium breve	-	-	-	1件: 97
254	Bifidobacterium infantis	1件: Bifidobacterium longum infantis	-	-	-	2件: 96, 97
255	Bifidobacterium infantis 35624	1件: Bifidobacterium longum infantis	-	-	-	2件: 96, 97
256	BIMEKIZUMAB	1件: Bimekizumab	1件: D11550	2件: IL17A, IL17F 💬	6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬	3件: 46, 97, 271
257	Bio-enhanced Curcumin Soft Gelatin Capsule	2件: Curcumin, Gelatin	2件: D00115 , D06892	-	-	1件: 97
258	Biological Drug	-	-	-	-	3件: 46, 96, 97
259	Biologically active human fecal microbiota	-	-	-	-	1件: 97
260	Biologics	-	-	-	-	3件: 46, 96, 97
261	Biopsies	-	-	-	-	1件: 97
262	Biosimilar	-	-	-	-	4件: 46, 96, 97, 271
263	Biosimilar Infliximab	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	3件: 46, 96, 97
264	BITTER CANDYTUFT FRESH PLANT EXTRACT	-	-	-	-	1件: 97
265	Bitterschleifenblume-ganzpflanze 1,5ml/10ml	-	-	-	-	1件: 97
266	BL-7040	-	-	-	-	1件: 97
267	Blood sample	-	-	-	-	20件: 8, 13, 46, 49, 51, 53, 61, 66, 84, 88, 96, 97, 107, 127, 235, 274, 280, 288, 294, 299
268	Blood samples	-	-	-	-	9件: 13, 41, 51, 61, 97, 227, 240, 271, 280
269	BMS-188667	-	-	-	-	9件: 46, 49, 53, 65, 96, 97, 107, 222, 271
270	BMS-936557	-	-	-	-	2件: 96, 97
271	BMS-986165	-	-	-	-	3件: 49, 96, 97
272	BMS-986166	-	-	-	-	1件: 97
273	BMS-986184	-	-	-	-	1件: 97
274	BMS986165	-	-	-	-	2件: 96, 97
275	Boulardii	-	-	-	-	2件: 96, 97
276	Bovine intestinal alkaline phosphatase (BIAP)	1件: Alkaline Phosphatase	-	-	-	1件: 97
277	Bovine-Calf Alkaline Phosphatase (BIAP)	1件: Alkaline Phosphatase	-	-	-	1件: 97
278	Bovine-Calf Alkaline Phosphatase BIAP	1件: Alkaline Phosphatase	-	-	-	1件: 97
279	BRAZIKUMAB	1件: Brazikumab	1件: D10912	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	2件: 96, 97
280	Brazikumab Induction Dose	1件: Brazikumab	1件: D10912	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	2件: 96, 97
281	Brazikumab Maintenance Dose	1件: Brazikumab	1件: D10912	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	2件: 96, 97
282	Brepocitinib 25 mg	-	-	-	-	2件: 96, 97
283	Brepocitinib 5 mg	-	-	-	-	2件: 96, 97
284	Broccoli	1件: Broccoli	-	-	-	3件: 36, 97, 299
285	BT	-	-	-	-	3件: 96, 97, 98
286	BT-11	-	-	-	-	2件: 96, 97
287	BT-11 (1000 mg)	-	-	-	-	1件: 97
288	BT-11 (500 mg)	-	-	-	-	1件: 97
289	BT-11 1000mg	-	-	-	-	3件: 96, 97, 98
290	BT-11 500 mg	-	-	-	-	2件: 96, 97
291	BT-11 Active	-	-	-	-	2件: 96, 97
292	BT051 200 mg	-	-	-	-	1件: 97
293	BT051 3200 mg	-	-	-	-	1件: 97
294	BT051 800 mg	-	-	-	-	1件: 97
295	Budenofalk 2mg rectal foam	-	-	-	-	1件: 97
296	Budenofalk 3mg	-	-	-	-	2件: 93, 97
297	Budenofalk rectal foam	-	-	-	-	1件: 97
298	Budenofalk® suppositories	-	-	-	-	1件: 97
299	Budenofalk® suppositories (BUS)	-	-	-	-	1件: 97
300	BUDESONIDE	1件: Budesonide	1件: D00246	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	9件: 66, 93, 94, 95, 96, 97, 98, 228, 299
301	Budesonide (6 mg)	1件: Budesonide	1件: D00246	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
302	Budesonide (9 mg)	1件: Budesonide	1件: D00246	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
303	Budesonide 6 mg prolonged-release capsule, hard (BUX-PVII prototype)	1件: Budesonide	1件: D00246	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
304	Budesonide 6 mg prolonged-release capsules, hard (BUX-PVII prototype)	1件: Budesonide	1件: D00246	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
305	Budesonide 9 mg capsules, hard (BUX-PV)	1件: Budesonide	1件: D00246	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
306	Budesonide 9 mg prolonged-release capsule, hard (BUX-PVII prototype)	1件: Budesonide	1件: D00246	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
307	Budesonide 9 mg prolonged-release capsules, hard (BUX-PVII prototype)	1件: Budesonide	1件: D00246	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
308	Budesonide MMX	1件: Budesonide	1件: D00246	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
309	Budesonide MMX 6 mg Tablet	1件: Budesonide	1件: D00246	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
310	Budesonide MMX®	1件: Budesonide	1件: D00246	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
311	Budesonide MMX® 6 mg	1件: Budesonide	1件: D00246	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
312	Budesonide MMX® 9 mg	1件: Budesonide	1件: D00246	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
313	Budesonide-MMX	1件: Budesonide	1件: D00246	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
314	Budesonide-MMX®	1件: Budesonide	1件: D00246	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
315	Budesonide-MMX® 6 mg	1件: Budesonide	1件: D00246	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
316	Budesonide-MMX® 9 mg	1件: Budesonide	1件: D00246	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
317	Budesonide-MMX™	1件: Budesonide	1件: D00246	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
318	Butanoic acid	1件: Butyric Acid	-	-	-	3件: 34, 51, 97
319	Butyrate	1件: Butyric Acid	-	-	-	4件: 46, 97, 156, 291
320	By demand	-	-	-	-	2件: 96, 97
321	Caffeine	1件: Caffeine	2件: D00528 , D01453	11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬	22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	8件: 2, 6, 21, 46, 78, 96, 97, 265
322	Calcio	1件: Calcium	-	-	-	4件: 13, 96, 97, 274
323	Calcitonin nasal spray (salmon)	1件: Salmon, unspecified	-	-	-	2件: 96, 97
324	Calcium	1件: Calcium	-	-	-	27件: 6, 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 156, 214, 215, 222, 224, 235, 265, 274, 298, 299
325	Caltrate	-	-	-	-	1件: 97
326	Cannabidiol	1件: Cannabidiol	1件: D10915	2件: CNR1, CNR2 💬	4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬	18件: 6, 8, 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271
327	Cannabis	1件: Medical Cannabis	-	-	-	7件: 2, 6, 13, 19, 90, 96, 97
328	Cannabis, Medical	1件: Medical Cannabis	-	-	-	5件: 2, 6, 13, 96, 97
329	Carbon	1件: Activated charcoal	-	-	-	6件: 6, 85, 86, 96, 97, 158
330	Carbon dioxide	2件: Activated charcoal, Carbon dioxide	1件: D00004	-	-	2件: 97, 158
331	Carnitine	1件: Levocarnitine	1件: D02176	-	-	9件: 5, 13, 58, 86, 96, 97, 265, 298, 316
332	Carrageenan	-	-	-	-	1件: 97
333	CARVI EXTRACTUM FLUIDUM	-	-	-	-	1件: 97
334	Casein	1件: Casein	-	-	-	1件: 97
335	Casein glycomacropeptide (CGMP)	1件: Casein	-	-	-	1件: 97
336	CAT-354	-	-	-	-	1件: 97
337	Catridecacog	1件: Catridecacog	1件: D10532	-	-	2件: 97, 288
338	CB-01-02	-	-	-	-	1件: 97
339	CB-01-05-MMX	-	-	-	-	1件: 97
340	CBP-307	-	-	-	-	1件: 97
341	CC	-	-	-	-	13件: 28, 46, 49, 51, 56, 84, 85, 96, 97, 98, 162, 202, 271
342	CC-10004	-	-	-	-	5件: 46, 56, 97, 162, 271
343	CD	-	-	-	-	8件: 6, 13, 46, 51, 63, 96, 97, 265
344	CD7 CAR T-cells	-	-	-	-	3件: 50, 96, 97
345	Ceftriaxone	1件: Ceftriaxone	1件: D07659	-	-	4件: 2, 6, 46, 97
346	Cefuroxime	1件: Cefuroxime	1件: D00262	-	-	2件: 97, 299
347	Certolizumab Pegol	1件: Certolizumab pegol	1件: D03441	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	8件: 37, 46, 49, 96, 97, 107, 226, 271
348	CGMP protein	-	-	-	-	1件: 97
349	Chloride	1件: Chloride ion	-	-	-	28件: 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 288, 296, 297, 299, 338
350	Chlorogenic Acid	1件: Chlorogenic Acid	-	-	-	1件: 97
351	CHOLECALCIFEROL	1件: Cholecalciferol	1件: D00188	1件: VDR 💬	5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬	9件: 13, 19, 34, 46, 49, 96, 97, 298, 299
352	Ciclosporin	1件: Cyclosporine	1件: D00184	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬	13件: 26, 46, 49, 50, 53, 55, 60, 61, 97, 222, 226, 228, 269
353	CICLOSPORINA	1件: Cyclosporine	1件: D00184	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬	4件: 49, 60, 97, 228
354	CIMZIA	1件: Certolizumab pegol	1件: D03441	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	5件: 46, 49, 96, 97, 271
355	Ciprofloxacin	1件: Ciprofloxacin	1件: D00186	-	-	5件: 2, 60, 96, 97, 299
356	CLA	-	-	-	-	1件: 97
357	CLA (Chlorogenic acid)	1件: Chlorogenic Acid	-	-	-	1件: 97
358	Clarithromycin	1件: Clarithromycin	1件: D00276	-	-	8件: 6, 63, 84, 96, 97, 222, 228, 299
359	Clipper	-	-	-	-	1件: 97
360	Clipper 30 cpr 5mg R.M.	-	-	-	-	1件: 97
361	CLIPPER*30CPR 5MG R.M.	-	-	-	-	1件: 97
362	Clotrimazole	1件: Clotrimazole	1件: D00282	-	-	1件: 97
363	CNTO 148	-	-	-	-	4件: 46, 84, 97, 271
364	CNTO-148	-	-	-	-	1件: 97
365	CNTO1275	-	-	-	-	6件: 46, 49, 84, 93, 96, 97
366	CNTO148	-	-	-	-	5件: 46, 84, 96, 97, 107
367	CNTO1959	-	-	-	-	4件: 37, 41, 96, 97
368	CNTO312	-	-	-	-	1件: 97
369	Coamoxiclav	-	-	-	-	1件: 97
370	COBITOLIMOD	1件: Cobitolimod	1件: D12275	1件: TLR9 💬	9件: African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬	1件: 97
371	Cobitolimod 250 mg	1件: Cobitolimod	1件: D12275	1件: TLR9 💬	9件: African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬	1件: 97
372	Cobitolimod 500 mg	1件: Cobitolimod	1件: D12275	1件: TLR9 💬	9件: African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬	1件: 97
373	Cobitolimod 500mg	1件: Cobitolimod	1件: D12275	1件: TLR9 💬	9件: African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬	1件: 97
374	Coffee	1件: Arabica coffee bean	-	-	-	1件: 97
375	COFFEE COAL	1件: Arabica coffee bean	-	-	-	1件: 97
376	COLAL PRED	-	-	-	-	1件: 97
377	COLAL-PRED	-	-	-	-	1件: 97
378	COLAL-PRED®	-	-	-	-	1件: 97
379	Colazide	-	-	-	-	1件: 97
380	Coltect	-	-	-	-	1件: 97
381	Combination Oral Budesonide and Rectal Hydrocortisone	2件: Budesonide, Hydrocortisone	2件: D00088 , D00246	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
382	Combination Product: Beclomethasone dipropionate in addition to MC-EVOO	1件: Beclomethasone dipropionate	1件: D00689	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
383	Combination Product: Beclomethasone dipropionate in addition to refined oil	1件: Beclomethasone dipropionate	1件: D00689	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
384	Combination Product: Humira (adalimumab)	1件: Adalimumab	1件: D02597	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
385	Conventional treatment	-	-	-	-	1件: 97
386	Conventional treatment (glucocoticoid, immunosupressive drugs and/or mesalazine)	1件: Mesalazine	1件: D00377	-	-	2件: 96, 97
387	Corticosteroid	-	-	-	-	9件: 13, 42, 43, 44, 45, 66, 96, 97, 222
388	Corticosteroids	-	-	-	-	12件: 41, 46, 49, 63, 64, 97, 107, 113, 164, 220, 296, 300
389	Corticosteroids +immune suppressive +amino salicylic acid	1件: Salicylic acid	1件: D00097	-	-	1件: 97
390	Corticosteroids only	-	-	-	-	1件: 97
391	CortimentMMX 9 mg	-	-	-	-	1件: 97
392	CosmoFer	-	-	-	-	3件: 86, 96, 97
393	CosmoFer 50mg/ml solution for infusion or injection	-	-	-	-	2件: 96, 97
394	Cotrimoxazole	-	-	-	-	2件: 85, 97
395	CP	-	-	-	-	6件: 6, 46, 96, 97, 107, 271
396	CP- 690 550	-	-	-	-	1件: 97
397	CP-690, 550-10	-	-	-	-	2件: 97, 107
398	CP-690,500 5 mg	-	-	-	-	1件: 97
399	CP-690,550	-	-	-	-	5件: 46, 96, 97, 107, 271
400	CP-690,550 10 mg	-	-	-	-	1件: 97
401	CP-690,550-10	-	-	-	-	5件: 46, 96, 97, 107, 271
402	CP690,550	-	-	-	-	2件: 46, 97
403	CS (corticosteroids) Only	-	-	-	-	1件: 97
404	CT-P13	-	-	-	-	4件: 46, 96, 97, 271
405	CT-P13 SC (Infliximab)	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	2件: 96, 97
406	Curcumin	1件: Curcumin	-	-	-	10件: 2, 13, 46, 67, 74, 94, 96, 97, 139, 299
407	Curcumin Supplementation	1件: Curcumin	-	-	-	1件: 97
408	Cyclosporin	1件: Cyclosporine	1件: D00184	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬	17件: 38, 46, 49, 50, 53, 56, 60, 62, 63, 93, 95, 97, 113, 164, 222, 274, 326
409	Cyclosporine	1件: Cyclosporine	1件: D00184	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬	37件: 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 107, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302
410	Cyclosporine (USAN)	1件: Cyclosporine	1件: D00184	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬	1件: 97
411	CYCLOSPORINE VS INFLIXIMAB	2件: Cyclosporine, Infliximab	2件: D00184 , D02598	6件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, TNF 💬	86件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Dopaminergic synapse, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Glucagon signaling pathway, Glutamatergic synapse, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Renin secretion, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Wnt signaling pathway, Yersinia infection, cGMP-PKG signaling pathway, mTOR signaling pathway 💬	1件: 97
412	CyCol	-	-	-	-	1件: 97
413	CyCol™	-	-	-	-	1件: 97
414	Cytochrome P450 (CYP) Substrates	-	-	-	-	2件: 96, 97
415	D-Proline	2件: D-Proline, Proline	1件: D00035	-	-	1件: 97
416	D.3.6.2.1 - valore: 45 / 0.45 mg/ml	-	-	-	-	1件: 97
417	D.3.6.2.1 - valore: 5 o 10 mg/kg	-	-	-	-	1件: 97
418	D3 VitaCaps®	-	-	-	-	2件: 96, 97
419	DACLIZUMAB	1件: Daclizumab	1件: D03639	1件: IL2RA 💬	11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬	8件: 13, 56, 60, 65, 97, 107, 283, 284
420	DACORTIN	-	-	-	-	1件: 97
421	DAND (14-Deoxyandrographolide)	-	-	-	-	1件: 97
422	DDAND (14-deoxy-11,12-didehydroandrographolide)	-	-	-	-	1件: 97
423	Decortin H	-	-	-	-	3件: 66, 97, 145
424	Decortin H 1 mg	-	-	-	-	1件: 97
425	Decortin H 10mg	-	-	-	-	1件: 97
426	Decortin H 20mg	-	-	-	-	1件: 97
427	Decortin H 50 mg	-	-	-	-	1件: 97
428	Decortin H 5mg	-	-	-	-	1件: 97
429	Dekavil	-	-	-	-	2件: 46, 97
430	Dekristol	-	-	-	-	2件: 13, 97
431	Delayed and extended release mesalazine	1件: Mesalazine	1件: D00377	-	-	1件: 97
432	Deligoparin	-	-	-	-	1件: 97
433	Delmitide acetate	1件: Acetate	-	-	-	1件: 97
434	DELTACORTENE	-	-	-	-	2件: 43, 97
435	Deltacortene 10 cpr 25mg	-	-	-	-	1件: 97
436	Deltacortene 20 cpr 5mg	-	-	-	-	1件: 97
437	DELTACORTENE FORTE*10CPR 25MG	-	-	-	-	2件: 46, 97
438	DELTACORTENE*20CPR 5MG	-	-	-	-	3件: 49, 97, 113
439	Dersalazina sodica	-	-	-	-	1件: 97
440	Dersalazine	1件: Dersalazine	-	-	-	1件: 97
441	Dersalazine sodium	1件: Dersalazine	-	-	-	1件: 97
442	Deucravacitinib	1件: Deucravacitinib	1件: D11817	1件: TYK2 💬	16件: Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis 💬	3件: 49, 96, 97
443	Dexamethasone	1件: Dexamethasone	1件: D00292	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	22件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299
444	Dexamethasone 21-phosphate	2件: Dexamethasone, Phosphate ion	1件: D00292	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
445	Dextran	1件: Dextran	1件: D00060	-	-	4件: 2, 62, 96, 97
446	DEXTRAN 1 FOR INJECTION	1件: Dextran	1件: D00060	-	-	1件: 97
447	Dextromethorphan	1件: Dextromethorphan	1件: D03742	6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬	20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬	11件: 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
448	Diet	-	-	-	-	4件: 86, 97, 240, 299
449	DIMS0150	-	-	-	-	1件: 97
450	Diosmin	1件: Diosmin	1件: D07858	-	-	3件: 46, 97, 265
451	Doxycyclin	1件: Doxycycline	2件: D00307 , D07876	-	-	2件: 97, 299
452	Doxycycline	1件: Doxycycline	2件: D00307 , D07876	-	-	17件: 13, 23, 28, 34, 46, 84, 85, 89, 96, 97, 158, 161, 162, 167, 227, 280, 299
453	Dukoral	1件: Recombinant Cholera Toxin B Subunit	-	-	-	1件: 97
454	Dupilumab	1件: Dupilumab	1件: D10354	1件: IL4R 💬	8件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬	5件: 51, 97, 98, 160, 162
455	E. coli Nissle	-	-	-	-	1件: 97
456	E. coli Nissle 1917 (Mutaflor®)	-	-	-	-	1件: 97
457	E400 elimination	-	-	-	-	1件: 97
458	E6007	-	-	-	-	1件: 97
459	Ecologic 825	-	-	-	-	1件: 97
460	EFAVALEUKIN ALFA	1件: Efavaleukin alfa	1件: D11612	-	-	2件: 49, 97
461	Efmarodocokin alfa	1件: Efmarodocokin alfa	1件: D11953	1件: IL22 💬	4件: Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬	2件: 96, 97
462	EGF enema	-	-	-	-	1件: 97
463	Eicosapentaenoic acid	1件: Icosapent	1件: D08061	-	-	6件: 49, 96, 97, 296, 297, 338
464	EMEA/H/C/000240	-	-	-	-	2件: 96, 97
465	EMEA/H/C/000481	-	-	-	-	1件: 97
466	Empagliflozin	1件: Empagliflozin	1件: D10459	1件: SLC5A2 💬	-	6件: 58, 65, 67, 72, 97, 257
467	Empagliflozin 10 MG	1件: Empagliflozin	1件: D10459	1件: SLC5A2 💬	-	2件: 58, 97
468	EN	-	-	-	-	3件: 6, 46, 97
469	Encapsulated faecal microbiota	-	-	-	-	1件: 97
470	Encapsulated faecal microbiota filtrate	-	-	-	-	1件: 97
471	Encapsulated Mesalamine Granules (eMG)	1件: Mesalazine	1件: D00377	-	-	1件: 97
472	Entecavir	1件: Entecavir	2件: D04008 , D07896	-	-	6件: 46, 56, 96, 97, 107, 271
473	Entocort CR	1件: Budesonide	1件: D00246	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	2件: 96, 97
474	Entocort EC® 3 mg	1件: Budesonide	1件: D00246	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
475	Entocort® CR	1件: Budesonide	1件: D00246	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
476	Entyvio	1件: Vedolizumab	1件: D08083	2件: ITGA4, ITGB7 💬	15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬	3件: 94, 96, 97
477	ENTYVIO - 300 MG - POLVERE PE RCONCENTRATO PER SOLUZIONE PER INFU	1件: Vedolizumab	1件: D08083	2件: ITGA4, ITGB7 💬	15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬	1件: 97
478	ENTYVIO - 300 MG - POLVERE PE RCONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) (20ML) - 1 FLACONCINO	1件: Vedolizumab	1件: D08083	2件: ITGA4, ITGB7 💬	15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬	2件: 96, 97
479	ENTYVIO - 300 MG - POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) (20ML) - 1 FLACONCINO	1件: Vedolizumab	1件: D08083	2件: ITGA4, ITGB7 💬	15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬	1件: 97
480	Entyvio 300 mg	1件: Vedolizumab	1件: D08083	2件: ITGA4, ITGB7 💬	15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬	1件: 97
481	Entyvio 300mg	1件: Vedolizumab	1件: D08083	2件: ITGA4, ITGB7 💬	15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬	1件: 97
482	Epaxal Berna (virosomal hepatitis A vaccine)	1件: Hepatitis A Vaccine	-	-	-	2件: 96, 97
483	Epidermal growth factor	-	-	-	-	1件: 97
484	Epidermal growth factor enema	-	-	-	-	1件: 97
485	Ergocalciferol	1件: Ergocalciferol	1件: D00187	1件: VDR 💬	5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬	5件: 46, 84, 96, 97, 299
486	Ethanol	1件: Ethanol	1件: D06542	-	-	3件: 97, 279, 280
487	Etrasimod	1件: Etrasimod	1件: D10930	5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬	3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬	3件: 96, 97, 98
488	Etrasimod L-arginine	2件: Arginine, Etrasimod	2件: D02982 , D10930	5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬	3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬	3件: 96, 97, 98
489	ETROLIZUMAB	1件: Etrolizumab	1件: D09901	1件: ITGB7 💬	11件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer 💬	2件: 96, 97
490	Etrozulimab	-	-	-	-	1件: 97
491	ExoFlo	-	-	-	-	2件: 96, 97
492	Exposure to golimumab	1件: Golimumab	1件: D04358	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
493	F8IL10	-	-	-	-	2件: 46, 97
494	Factor XIII	1件: Factor XIII (human)	-	-	-	3件: 51, 97, 288
495	Faecal matter	-	-	-	-	1件: 97
496	Faecal Microbiota Transplant	-	-	-	-	1件: 97
497	Faecal microbiota transplantation	-	-	-	-	5件: 46, 84, 96, 97, 271
498	FE 999301	-	-	-	-	2件: 96, 97
499	Fecal Microbial transplant	-	-	-	-	2件: 96, 97
500	Fecal Microbial Transplantation	-	-	-	-	2件: 96, 97
501	Fecal microbiota	-	-	-	-	3件: 13, 96, 97
502	Fecal microbiota capsule	-	-	-	-	1件: 97
503	Fecal Microbiota Enema	-	-	-	-	1件: 97
504	Fecal Microbiota Transplant	-	-	-	-	2件: 96, 97
505	Fecal Microbiota Transplant (FMT)	-	-	-	-	2件: 96, 97
506	Fecal microbiota transplantation	-	-	-	-	5件: 2, 66, 94, 96, 97
507	Fecal Microbiota Transplantation (FMT)	-	-	-	-	2件: 96, 97
508	Fecal Microbiota Transplantation (FMT), OpenBiome	-	-	-	-	1件: 97
509	Fecal Microbiota Transplantation by Intra-rectal enemas	-	-	-	-	1件: 97
510	Fecal Microbiota Transplantation by Stool capsules	-	-	-	-	1件: 97
511	Fecal transplantation	-	-	-	-	1件: 97
512	Fenofibrate	1件: Fenofibrate	1件: D00565	1件: PPARA 💬	10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬	6件: 8, 79, 93, 94, 97, 265
513	Fenofibrate 160mg	1件: Fenofibrate	1件: D00565	1件: PPARA 💬	10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬	1件: 97
514	FERRIC CARBOXYMALTOSE	1件: Ferric carboxymaltose	1件: D08920	-	-	4件: 86, 96, 97, 299
515	Ferrous sulphate	-	-	-	-	2件: 96, 97
516	FILGOTINIB	1件: Filgotinib	1件: D10871	1件: JAK1 💬	27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬	6件: 46, 53, 96, 97, 222, 271
517	Film-coated tablet	-	-	-	-	1件: 97
518	FITC-Adalimumab	1件: Adalimumab	1件: D02597	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	2件: 96, 97
519	Flagyl	1件: Metronidazole	1件: D00409	-	-	2件: 96, 97
520	Flaxseed	1件: Flax seed	-	-	-	2件: 97, 299
521	Flaxseed lignan-enriched complex (FLC)	1件: Flax seed	-	-	-	1件: 97
522	Flixabi	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	2件: 96, 97
523	Fluorescein	1件: Fluorescein	1件: D01261	-	-	2件: 22, 97
524	Flupentixol	1件: Flupentixol	1件: D01044	2件: DRD1, DRD2 💬	11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬	1件: 97
525	FMT	-	-	-	-	2件: 96, 97
526	FMT enema	-	-	-	-	1件: 97
527	FMT infusions	-	-	-	-	1件: 97
528	FMT oral	-	-	-	-	1件: 97
529	Fosfomycin	1件: Fosfomycin	1件: D04253	-	-	2件: 96, 97
530	FOSFOMYCIN DISODIUM	1件: Fosfomycin	1件: D04253	-	-	1件: 97
531	FP-110	-	-	-	-	1件: 97
532	FP-CYA-050	-	-	-	-	1件: 97
533	FP-CYA-053	-	-	-	-	1件: 97
534	Freeze-dried black raspberry powder	1件: Raspberry	1件: D09179	-	-	1件: 97
535	Frondanol	-	-	-	-	1件: 97
536	Fully human IgG1 monoclonal antibody specific for TL1A	-	-	-	-	2件: 96, 97
537	G1567970	-	-	-	-	3件: 46, 53, 97
538	G321605	-	-	-	-	3件: 85, 96, 97
539	Ganciclovir	1件: Ganciclovir	1件: D00333	-	-	1件: 97
540	Gastro-resistant phosphatidylcholine granules	1件: Lecithin	1件: D04682	-	-	1件: 97
541	GB004	-	-	-	-	1件: 97
542	GB004-HCl	-	-	-	-	1件: 97
543	GED-0301	-	-	-	-	2件: 96, 97
544	GED-0507-34-LEVO	1件: GED-0507-34-Levo	-	-	-	1件: 97
545	GED-0507-34-Levo 160 mg	1件: GED-0507-34-Levo	-	-	-	1件: 97
546	GED-0507-34-Levo 80 mg	1件: GED-0507-34-Levo	-	-	-	1件: 97
547	GED0507	-	-	-	-	1件: 97
548	Gelatin	1件: Gelatin	2件: D00115 , D06892	-	-	5件: 28, 62, 78, 97, 269
549	GI-270384	-	-	-	-	1件: 97
550	Gliolan	1件: Aminolevulinic acid	1件: D07567	-	-	1件: 97
551	GLPG0974	-	-	-	-	1件: 97
552	GLPG1205	-	-	-	-	3件: 85, 96, 97
553	GLPG3970	-	-	-	-	3件: 46, 53, 97
554	Glucose	1件: Dextrose, unspecified form	-	-	-	12件: 2, 6, 13, 49, 50, 66, 86, 88, 96, 97, 257, 299
555	Glutamine	1件: L-Glutamine	1件: D00015	-	-	8件: 87, 89, 96, 97, 113, 222, 245, 299
556	Glycyrrhiza	1件: Glycyrrhiza glabra	-	-	-	2件: 53, 97
557	Glycyrrhiza glabra	1件: Glycyrrhiza glabra	-	-	-	1件: 97
558	GLYCYRRHIZA GLABRA ROOT	1件: Glycyrrhiza glabra	-	-	-	1件: 97
559	GM-CSF, fosfomycin and metronidazole	2件: Fosfomycin, Metronidazole	2件: D00409 , D04253	-	-	1件: 97
560	Gold	1件: Gold	-	-	-	43件: 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 63, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 167, 171, 193, 218, 222, 224, 226, 227, 230, 271, 291, 296, 298, 310, 318
561	GOLIMUMAB	1件: Golimumab	1件: D04358	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	8件: 46, 56, 84, 96, 97, 107, 270, 271
562	Golimumab (GLM)	1件: Golimumab	1件: D04358	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
563	Golimumab (Optimization)	1件: Golimumab	1件: D04358	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
564	Golimumab 1 mg per kg	1件: Golimumab	1件: D04358	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
565	Golimumab 100 mg	1件: Golimumab	1件: D04358	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	2件: 46, 97
566	Golimumab 2 mg per kg	1件: Golimumab	1件: D04358	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
567	Golimumab 200 mg	1件: Golimumab	1件: D04358	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
568	Golimumab 4 mg per kg	1件: Golimumab	1件: D04358	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
569	Golimumab 400 mg	1件: Golimumab	1件: D04358	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
570	Golimumab 50 mg	1件: Golimumab	1件: D04358	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	2件: 46, 97
571	Golimumab 50 mg in patients <80 kg and Golimumab 100 mg in patients >80 kg	1件: Golimumab	1件: D04358	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
572	Golimumab Dose 1	1件: Golimumab	1件: D04358	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
573	Golimumab Dose 2	1件: Golimumab	1件: D04358	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
574	Golimumab Liquid in prefilled syringe	1件: Golimumab	1件: D04358	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	4件: 46, 84, 97, 107
575	Golimumab Liquid in Vial	1件: Golimumab	1件: D04358	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	3件: 46, 97, 271
576	Golimumab Prefilled Syringe	1件: Golimumab	1件: D04358	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
577	Golimumab treatment optimization.	1件: Golimumab	1件: D04358	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
578	Gralise	-	-	-	-	2件: 97, 226
579	Granulated mesalamine	1件: Mesalazine	1件: D00377	-	-	1件: 97
580	Grapefruit	1件: Grapefruit	-	-	-	5件: 6, 46, 50, 83, 97
581	Group 1- Control Diet	-	-	-	-	1件: 97
582	Group 2- UCD Diet	-	-	-	-	1件: 97
583	GS-4875	-	-	-	-	1件: 97
584	GS-5745	1件: GS-5745	-	-	-	4件: 46, 96, 97, 299
585	GS-5745 IV	1件: GS-5745	-	-	-	1件: 97
586	GS-5745 SC	1件: GS-5745	-	-	-	1件: 97
587	GS-6034	-	-	-	-	4件: 46, 53, 96, 97
588	GSK1399686	-	-	-	-	1件: 97
589	GSK1605786	-	-	-	-	2件: 96, 97
590	GSK1605786A	-	-	-	-	2件: 96, 97
591	GSK2586184 400mg	-	-	-	-	1件: 97
592	GSK2831781	-	-	-	-	1件: 97
593	GSK2831781 - Double Blind Phase	-	-	-	-	1件: 97
594	GSK2831781 - Open Label phase	-	-	-	-	1件: 97
595	GSK2982772	-	-	-	-	2件: 46, 97
596	GSK2982772A, where A denotes the free base	-	-	-	-	2件: 46, 97
597	Guaiazulene	1件: Guaiazulen	-	-	-	1件: 97
598	Guselkum	-	-	-	-	1件: 97
599	GUSELKUMAB	1件: Guselkumab	1件: D10438	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	5件: 37, 41, 51, 96, 97
600	Guselkumab Dose 1	1件: Guselkumab	1件: D10438	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	3件: 51, 96, 97
601	Guselkumab Dose 2	1件: Guselkumab	1件: D10438	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	3件: 51, 96, 97
602	Guselkumab Dose 3	1件: Guselkumab	1件: D10438	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	2件: 96, 97
603	GWP42003	-	-	-	-	1件: 97
604	H02AB	-	-	-	-	1件: 97
605	HE3286	1件: HE3286	-	-	-	2件: 46, 97
606	Hemay007	-	-	-	-	1件: 97
607	Hepatitis A Vaccine	1件: Hepatitis A Vaccine	-	-	-	3件: 46, 96, 97
608	Herbal treatment (SA100)	-	-	-	-	1件: 97
609	Hextend	1件: Hydroxyethyl Starch	1件: D03335	-	-	2件: 96, 97
610	HF2	-	-	-	-	1件: 97
611	Hgd40	-	-	-	-	1件: 97
612	HGS1025	-	-	-	-	1件: 97
613	High dose	-	-	-	-	1件: 97
614	High Dose Budesonide	1件: Budesonide	1件: D00246	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
615	High Dose MT-1303	-	-	-	-	1件: 97
616	HLADQA1*05A>G screening	-	-	-	-	2件: 96, 97
617	HM201	-	-	-	-	2件: 96, 97
618	HMPL-004	-	-	-	-	2件: 96, 97
619	HMPL-004 1800 mg/day	-	-	-	-	1件: 97
620	HMPL-004 2400 mg/day	-	-	-	-	1件: 97
621	HMPL-004 high dose	-	-	-	-	1件: 97
622	HMPL-004 low dose	-	-	-	-	1件: 97
623	HMPL004-6599	-	-	-	-	2件: 96, 97
624	Hulio	1件: Adalimumab	1件: D02597	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	2件: 96, 97
625	HuM291	-	-	-	-	2件: 96, 97
626	HuM291)	-	-	-	-	1件: 97
627	Human anti-IP10 monoclonal antibody	-	-	-	-	2件: 96, 97
628	Human Anti-TNF IgG1 Monoclonal Antibody	-	-	-	-	3件: 46, 97, 271
629	Human anti-TNF-alpha monoclonal antibody	-	-	-	-	3件: 46, 97, 107
630	Human Anti-TNFalfa	-	-	-	-	3件: 46, 97, 271
631	Humanized recombinant IgG4 monoclonal antibody against CD-127	-	-	-	-	1件: 97
632	HUMIRA	-	-	-	-	9件: 46, 56, 84, 96, 97, 107, 160, 269, 271
633	Humira (adalimumab original)	1件: Adalimumab	1件: D02597	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	2件: 96, 97
634	HUMIRA - 40 MG SOLUZIONE INIETTABILE USO SOTTOCUTANEO 1 SIRINGA PRERIEMPITA 0.8 ML + 1 TAMPONE IMBEVUTO DI ALCOL IN UN BLISTER	-	-	-	-	2件: 56, 97
635	Humira 20 mg solution for injection in pre-filled syringe (20 mg/0.2mL)	1件: Adalimumab	1件: D02597	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
636	Humira 40 mg solution for injection in pre-filled syringe	1件: Adalimumab	1件: D02597	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	3件: 46, 96, 97
637	Humira 40 mg solution for injection in pre-filled syringe (40 mg/0.4 mL)	1件: Adalimumab	1件: D02597	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
638	Humira 40 mg solution for injection in pre-filled syringes	-	-	-	-	1件: 97
639	Humira 40 mg/0.8 ml solution for injection	1件: Adalimumab	1件: D02597	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	4件: 46, 96, 97, 271
640	Humira 40 mg/0.8 ml solution for injection for paediatric use	1件: Adalimumab	1件: D02597	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
641	HUMIRA 40Mg Solution for Injection	-	-	-	-	2件: 96, 97
642	Humira 80 mg solution for injection in pre-filled syringe (80 mg/0.8 mL)	1件: Adalimumab	1件: D02597	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
643	HUMIRA ®	1件: Adalimumab	1件: D02597	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	2件: 96, 97
644	Humira®	-	-	-	-	5件: 46, 96, 97, 107, 271
645	Hyaluronate	1件: Hyaluronic acid	1件: D08043	-	-	2件: 53, 97
646	Hydrocortisone	1件: Hydrocortisone	1件: D00088	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	10件: 6, 41, 46, 53, 75, 78, 81, 83, 97, 299
647	HYDROCORTISONE ACETATE	3件: Acetate, Hydrocortisone, Hydrocortisone acetate	2件: D00088 , D00165	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
648	HYDROCORTISONE SODIUM SUCCINATE	1件: Hydrocortisone	1件: D00088	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	3件: 81, 83, 97
649	Hydrogen	1件: Hydrogen	-	-	-	6件: 5, 6, 17, 83, 97, 226
650	Hydroxide	1件: Hydroxide ion	-	-	-	5件: 11, 46, 96, 97, 284
651	Hydroxocobalamin	1件: Hydroxocobalamin	1件: D01027	-	-	1件: 97
652	Hydroxocobalamin with Butyrate	2件: Butyric Acid, Hydroxocobalamin	1件: D01027	-	-	1件: 97
653	Hydroxychloroquine	1件: Hydroxychloroquine	1件: D08050	-	-	27件: 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299
654	IBD98-M	-	-	-	-	1件: 97
655	IBD98-M Delayed-release Capsules	1件: Manganese citrate	-	-	-	1件: 97
656	Iberogast N	-	-	-	-	1件: 97
657	IBI112	-	-	-	-	1件: 97
658	IDOFORM®Travel	-	-	-	-	1件: 97
659	IDROCORTISONE ACETATO	-	-	-	-	1件: 97
660	IL-22Fc	1件: Efmarodocokin alfa	1件: D11953	1件: IL22 💬	4件: Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬	2件: 96, 97
661	IM90838	-	-	-	-	3件: 13, 96, 97
662	Imolope	-	-	-	-	1件: 97
663	IMU-838	-	-	-	-	3件: 13, 96, 97
664	Imuran	1件: Azathioprine	1件: D00238	-	-	2件: 96, 97
665	Imurek	-	-	-	-	1件: 97
666	Imurek 25mg Filmtabletten	-	-	-	-	1件: 97
667	Imurek 50mg Filmtabletten	-	-	-	-	1件: 97
668	IMUREL	-	-	-	-	4件: 13, 46, 96, 97
669	INCB039110	-	-	-	-	2件: 51, 97
670	Indigo	1件: Indigo	-	-	-	3件: 97, 289, 300
671	Infectofos	-	-	-	-	1件: 97
672	Inflectra	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	4件: 46, 56, 96, 97
673	Inflectra 100 mg	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
674	Inflectra 100 mg powder for concentrate for solution for infusion	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	2件: 96, 97
675	Infliximab	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	26件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271
676	Infliximab (IFX)	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
677	Infliximab 10 mg/kg	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	3件: 46, 96, 97
678	Infliximab 5 mg/kg	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	2件: 96, 97
679	Infliximab [infliximab biosimilar 3]	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	4件: 37, 46, 96, 97
680	Infliximab and adalimumab	2件: Adalimumab, Infliximab	2件: D02597 , D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	2件: 96, 97
681	Infliximab induction	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
682	Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab	5件: Adalimumab, Golimumab, Infliximab, Ustekinumab, Vedolizumab	5件: D02597 , D02598 , D04358 , D08083 , D09214	6件: IL12A, IL12B, IL23A, ITGA4, ITGB7, TNF 💬	81件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, ECM-receptor interaction, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	2件: 96, 97
683	Infliximab therapeutic drug monitoring	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	2件: 96, 97
684	Infliximab, adalimumab, certolizumab pegol	3件: Adalimumab, Certolizumab pegol, Infliximab	3件: D02597 , D02598 , D03441	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	2件: 96, 97
685	Infliximab, adalimumab, golimumab, vedolizumab, ustekinumab	5件: Adalimumab, Golimumab, Infliximab, Ustekinumab, Vedolizumab	5件: D02597 , D02598 , D04358 , D08083 , D09214	6件: IL12A, IL12B, IL23A, ITGA4, ITGB7, TNF 💬	81件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, ECM-receptor interaction, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
686	Innovator infliximab	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	3件: 46, 96, 97
687	Inositol	1件: Inositol	1件: D08079	-	-	2件: 96, 97
688	Interferon Beta	1件: Human interferon beta	-	-	-	6件: 13, 20, 26, 50, 96, 97
689	INTERFERON BETA-1A	2件: Human interferon beta, Interferon beta-1a	1件: D04554	2件: IFNAR1, IFNAR2 💬	18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬	4件: 13, 26, 96, 97
690	Interferon-Beta	1件: Human interferon beta	-	-	-	2件: 13, 97
691	Interferon-beta-1a	2件: Human interferon beta, Interferon beta-1a	1件: D04554	2件: IFNAR1, IFNAR2 💬	18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬	2件: 13, 97
692	Interferon-beta-1a, 44 microgram	2件: Human interferon beta, Interferon beta-1a	1件: D04554	2件: IFNAR1, IFNAR2 💬	18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬	1件: 97
693	Interferon-beta-1a, 66 microgram	2件: Human interferon beta, Interferon beta-1a	1件: D04554	2件: IFNAR1, IFNAR2 💬	18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬	1件: 97
694	INTERLEUKIN 2	-	-	-	-	9件: 46, 49, 51, 56, 63, 95, 96, 97, 271
695	INTERLEUKIN-2	1件: Human interleukin-2	-	-	-	10件: 2, 35, 49, 50, 53, 55, 65, 96, 97, 162
696	Interleukin-2 (aldesleukin).	2件: Aldesleukin, Human interleukin-2	1件: D00748	3件: IL2RA, IL2RB, IL2RG 💬	14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬	2件: 96, 97
697	Intestinal flora capsule	-	-	-	-	1件: 97
698	Intravenous (IV) infusions	-	-	-	-	2件: 13, 97
699	Iron	1件: Iron	-	-	-	6件: 18, 96, 97, 238, 254, 284
700	Iron sucrose	2件: Iron sucrose, Sucrose	2件: D00025 , D04616	-	-	3件: 62, 96, 97
701	Iron sulphate	1件: Iron	-	-	-	2件: 96, 97
702	Iron sulphate 200mg coated tablets	1件: Iron	-	-	-	2件: 96, 97
703	Iron supplement 300-600 mg/day	1件: Iron	-	-	-	2件: 96, 97
704	Iron(III)- hydroxide dextran complex	3件: Dextran, Hydroxide ion, Iron	1件: D00060	-	-	2件: 96, 97
705	Itacitinib	1件: Itacitinib	1件: D10944	1件: JAK1 💬	27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬	4件: 46, 51, 97, 228
706	ITACITINIB ADIPATE	2件: Iron (III) oxide adipate, Itacitinib	1件: D10944	1件: JAK1 💬	27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬	2件: 97, 228
707	IV Corticosteroid	-	-	-	-	1件: 97
708	Janus Kinase Inhibitor	-	-	-	-	2件: 46, 97
709	JNJ-54781532 150 mg once daily	-	-	-	-	1件: 97
710	JNJ-54781532 25 mg once daily	-	-	-	-	1件: 97
711	JNJ-54781532 75 mg once daily	-	-	-	-	1件: 97
712	JNJ-54781532 75 mg twice daily	-	-	-	-	1件: 97
713	JNJ-54781532-AAD-10 mg	-	-	-	-	1件: 97
714	JNJ-54781532-AAD-30 mg	-	-	-	-	1件: 97
715	JNJ-54781532-AAD-5 mg	-	-	-	-	1件: 97
716	JNJ-64841829	-	-	-	-	1件: 97
717	JNJ-64841842	-	-	-	-	1件: 97
718	JNJ-64841855	-	-	-	-	1件: 97
719	JNJ-64841894	-	-	-	-	1件: 97
720	JNJ-64841907	-	-	-	-	1件: 97
721	JNJ-64841920	-	-	-	-	1件: 97
722	JNJ-64841933	-	-	-	-	1件: 97
723	JNJ-64841946	-	-	-	-	1件: 97
724	JNJ-66525433	-	-	-	-	1件: 97
725	JNJ-72537634	-	-	-	-	1件: 97
726	JNJ-78934804	-	-	-	-	2件: 96, 97
727	K(D)PT	-	-	-	-	1件: 97
728	Kamillenblüten 3ml/10ml	-	-	-	-	1件: 97
729	Kappaproct	-	-	-	-	1件: 97
730	KBL697	-	-	-	-	1件: 97
731	KdPT	-	-	-	-	1件: 97
732	KHK4083	-	-	-	-	1件: 97
733	Kremezin	-	-	-	-	2件: 96, 97
734	Kremezin®, Spherical Adsorptive Carbon	1件: Activated charcoal	-	-	-	2件: 96, 97
735	KRP203	-	-	-	-	1件: 97
736	KRP203A	-	-	-	-	1件: 97
737	Kyo-Dophilus	-	-	-	-	1件: 97
738	Kümmel 2ml/10ml	-	-	-	-	1件: 97
739	L-arginine	1件: Arginine	1件: D02982	-	-	8件: 46, 67, 78, 96, 97, 98, 113, 299
740	L-Carnitine	1件: Levocarnitine	1件: D02176	-	-	7件: 13, 86, 96, 97, 265, 298, 316
741	L-Lysyl-D-Prolyl-L-Threonine Acetate	2件: Acetate, Threonine	1件: D00041	-	-	1件: 97
742	L-Lysyl-D-Prolyl-LThreonine acetate, lyophilisate	1件: Acetate	-	-	-	1件: 97
743	Lactated Ringers	-	-	-	-	2件: 96, 97
744	Lactobacillus	1件: Lactobacillus delbrueckii bulgaricus	-	-	-	5件: 6, 46, 51, 97, 299
745	Lactobacillus casei	1件: Lactobacillus casei	1件: D04351	-	-	3件: 6, 97, 296
746	Lactobacillus casei DG	1件: Lactobacillus casei	1件: D04351	-	-	1件: 97
747	Lactobacillus GG	1件: Lactobacillus delbrueckii bulgaricus	-	-	-	1件: 97
748	Lactobacillus plantarum	1件: Lactobacillus plantarum	-	-	-	3件: 6, 97, 156
749	LACTOBACILLUS REUTERI	1件: Lactobacillus reuteri	-	-	-	2件: 97, 299
750	Lactobacillus rhamnosus GG ATCC 53103	1件: Lactobacillus delbrueckii bulgaricus	-	-	-	1件: 97
751	Lactobacillus salivarius	1件: Lactobacillus salivarius	-	-	-	2件: 96, 97
752	Lactobacillus salivarius UCC118	1件: Lactobacillus salivarius	-	-	-	2件: 96, 97
753	Lactobacilus acidophilus & bifidobacterium animalis/lactis	1件: Lactobacillus acidophilus	1件: D04349	-	-	1件: 97
754	Lactose	1件: Lactose	2件: D00046 , D03226	-	-	6件: 2, 6, 13, 97, 228, 310
755	Lactose in water	2件: Lactose, Water	3件: D00001 , D00046 , D03226	-	-	1件: 97
756	LC51-0255	-	-	-	-	1件: 97
757	LDP-02	-	-	-	-	2件: 96, 97
758	LEVOCARNITINE	1件: Levocarnitine	1件: D02176	-	-	3件: 3, 53, 97
759	Levocarnitine propyl hydrochloride	1件: Levocarnitine	1件: D02176	-	-	1件: 97
760	Linaclotide	1件: Linaclotide	1件: D09355	1件: GUCY2C 💬	2件: Metabolic pathways, Purine metabolism 💬	2件: 6, 97
761	LIXACOL	-	-	-	-	1件: 97
762	Loperamide	1件: Loperamide	1件: D08144	3件: OPRD1, OPRK1, OPRM1 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬	2件: 13, 97
763	Loperamide hydrochloride	1件: Loperamide	1件: D08144	3件: OPRD1, OPRK1, OPRM1 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬	1件: 97
764	Losartan	1件: Losartan	1件: D08146	1件: AGTR1 💬	16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	17件: 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299
765	Low dose	-	-	-	-	1件: 97
766	Low Dose Budesonide	1件: Budesonide	1件: D00246	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
767	Low Dose MT-1303	-	-	-	-	1件: 97
768	Low dose naltrexone	1件: Naltrexone	1件: D05113	3件: OPRD1, OPRK1, OPRM1 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬	2件: 96, 97
769	Low FODMAP	-	-	-	-	1件: 97
770	LT-02	-	-	-	-	1件: 97
771	LT-02 (modified-release PC pellets)	1件: Manganese citrate	-	-	-	1件: 97
772	Lumbar puncture	-	-	-	-	4件: 13, 96, 97, 127
773	Lusvertikimab	-	-	-	-	1件: 97
774	LX1606	-	-	-	-	1件: 97
775	LY3074828	-	-	-	-	3件: 37, 96, 97
776	LY3471851	-	-	-	-	2件: 49, 97
777	LYC-30937	-	-	-	-	1件: 97
778	LYC-30937-EC	-	-	-	-	1件: 97
779	LYS006	-	-	-	-	1件: 97
780	Lysine	1件: Lysine	1件: D02304	-	-	4件: 13, 97, 228, 299
781	Lysine-D-Proline-Threonine	4件: D-Proline, Lysine, Proline, Threonine	3件: D00035 , D00041 , D02304	-	-	1件: 97
782	Magnesium	1件: Magnesium	-	-	-	15件: 6, 11, 46, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298
783	Magnesium citrate	2件: Magnesium, Magnesium citrate	1件: D03265	-	-	1件: 97
784	Maltodextrin	1件: Maltodextrin	1件: D02329	-	-	4件: 6, 13, 96, 97
785	Maltose	1件: Maltose	1件: D00044	-	-	2件: 96, 97
786	Mango	1件: Mango	-	-	-	2件: 96, 97
787	Mango polyphenolics	1件: Mango	-	-	-	2件: 96, 97
788	Mare´s milk	-	-	-	-	2件: 96, 97
789	MATRICARIA FLOWER	1件: Chamomile	1件: D09212	-	-	1件: 97
790	MATRICARIA RECUTITA L. FLOS	-	-	-	-	1件: 97
791	Maximal oral 5ASA	-	-	-	-	1件: 97
792	MD-0901	-	-	-	-	1件: 97
793	MDX-1100	-	-	-	-	3件: 46, 96, 97
794	MDX-1100 (anti-CXCL10 human monoclonal antibody)	-	-	-	-	1件: 97
795	MEDI2070	-	-	-	-	2件: 96, 97
796	MEDI7183 high dose	-	-	-	-	1件: 97
797	MEDI7183 low dose	-	-	-	-	1件: 97
798	MEDI7183 medium dose	-	-	-	-	1件: 97
799	Medical Cannabis	1件: Medical Cannabis	-	-	-	3件: 6, 96, 97
800	Melatonin	1件: Melatonin	1件: D08170	2件: MTNR1A, MTNR1B 💬	2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬	12件: 6, 8, 13, 37, 46, 49, 72, 78, 90, 97, 145, 202
801	MELISSAE FOLII DRY AQUEOUS EXTRACT	-	-	-	-	1件: 97
802	Melissenblätter 15ml/10ml	-	-	-	-	1件: 97
803	Melitracen	1件: Melitracen	1件: D08171	-	-	1件: 97
804	MENTHA × PIPERITA L. FOLIUM	-	-	-	-	1件: 97
805	Mercaptopurine	1件: Mercaptopurine	2件: D00161 , D04931	1件: HPRT1 💬	4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬	4件: 65, 96, 97, 164
806	Mercaptopurine (Puri-Nethol)	1件: Mercaptopurine	2件: D00161 , D04931	1件: HPRT1 💬	4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬	1件: 97
807	Mercaptopurine (Purinethol)	1件: Mercaptopurine	2件: D00161 , D04931	1件: HPRT1 💬	4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬	1件: 97
808	Mesalamin	-	-	-	-	1件: 97
809	Mesalamine	1件: Mesalazine	1件: D00377	-	-	4件: 96, 97, 98, 164
810	Mesalamine Delayed Release Tablets 400mg	2件: Manganese citrate, Mesalazine	1件: D00377	-	-	1件: 97
811	Mesalamine Enema	1件: Mesalazine	1件: D00377	-	-	1件: 97
812	Mesalamine Granules	1件: Mesalazine	1件: D00377	-	-	1件: 97
813	Mesalamine Once-Daily	1件: Mesalazine	1件: D00377	-	-	1件: 97
814	Mesalamine Twice-Daily	1件: Mesalazine	1件: D00377	-	-	1件: 97
815	Mesalamine, 5-aminosalicylic acid [5-ASA]	2件: Aminosalicylic acid, Mesalazine	2件: D00162 , D00377	-	-	1件: 97
816	Mesalamine, 5-ASA	1件: Mesalazine	1件: D00377	-	-	1件: 97
817	MESALAZINA	1件: Mesalazine	1件: D00377	-	-	1件: 97
818	Mesalazine	1件: Mesalazine	1件: D00377	-	-	3件: 46, 96, 97
819	Mesalazine (3,600 mg)	1件: Mesalazine	1件: D00377	-	-	1件: 97
820	Mesalazine (Asacol®)	1件: Mesalazine	1件: D00377	-	-	1件: 97
821	Mesalazine - TID 1000 mg	1件: Mesalazine	1件: D00377	-	-	1件: 97
822	Mesalazine - TID 2x 500 mg	1件: Mesalazine	1件: D00377	-	-	1件: 97
823	Mesalazine 1000 mg gastro-resistant tablets	1件: Mesalazine	1件: D00377	-	-	1件: 97
824	Mesalazine 250Mg	1件: Mesalazine	1件: D00377	-	-	1件: 97
825	Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet	2件: Mesalazine, Nitazoxanide	2件: D00377 , D02486	-	-	1件: 97
826	Mesalazine 4G Enema	1件: Mesalazine	1件: D00377	-	-	1件: 97
827	Mesalazine 500 mg gastro-resistant tablets (Salofa	1件: Mesalazine	1件: D00377	-	-	1件: 97
828	Mesalazine 500 mg gastro-resistant tablets (Salofalk® 500 mg)	1件: Mesalazine	1件: D00377	-	-	1件: 97
829	Mesalazine Enema	1件: Mesalazine	1件: D00377	-	-	1件: 97
830	Mesalazine liquid enema	1件: Mesalazine	1件: D00377	-	-	1件: 97
831	Mesalazine slow-release granules	1件: Mesalazine	1件: D00377	-	-	1件: 97
832	Mesalazine tablet	1件: Mesalazine	1件: D00377	-	-	1件: 97
833	Mesalazine with hydrocortisone sodium succinate	2件: Hydrocortisone, Mesalazine	2件: D00088 , D00377	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
834	Mesalazinum	1件: Mesalazine	1件: D00377	-	-	1件: 97
835	MESENCHYMAL CELLS	-	-	-	-	1件: 97
836	Mesenchymal stem cells (MSCs)	-	-	-	-	4件: 13, 36, 96, 97
837	Mesenchymal Stromal Cells	1件: Human Umbilical Cord Mesenchymal Stem Cells	-	-	-	10件: 2, 36, 49, 51, 60, 96, 97, 107, 274, 284
838	MET-2	-	-	-	-	1件: 97
839	Metformin	1件: Metformin	1件: D04966	2件: PRKAA1, PRKAA2 💬	20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬	25件: 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 218, 225, 233, 265, 285, 299, 301
840	Metformin 500 mg TID Oral Tablet	1件: Metformin	1件: D04966	2件: PRKAA1, PRKAA2 💬	20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬	1件: 97
841	Methotrexate	1件: Methotrexate	1件: D00142	2件: DHFR, DHFR2 💬	5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬	38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331
842	Methotrexate bellon	1件: Methotrexate	1件: D00142	2件: DHFR, DHFR2 💬	5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬	1件: 97
843	Methotrexate bellon 25mg/ml	1件: Methotrexate	1件: D00142	2件: DHFR, DHFR2 💬	5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬	1件: 97
844	METHOTREXATE DISODIUM	1件: Methotrexate	1件: D00142	2件: DHFR, DHFR2 💬	5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬	5件: 46, 96, 97, 107, 271
845	Methotrexate injection	1件: Methotrexate	1件: D00142	2件: DHFR, DHFR2 💬	5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬	2件: 96, 97
846	METHYLENE BLUE	1件: Methylene blue	2件: D02312 , D10537	-	-	1件: 97
847	Methylene blue 25mg tablets	1件: Methylene blue	2件: D02312 , D10537	-	-	1件: 97
848	Methylprednisolone	1件: Methylprednisolone	1件: D00407	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	46件: 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296
849	METHYLPREDNISOLONE SODIUM HEMISUCCINATE	1件: Methylprednisolone	1件: D00407	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	2件: 13, 97
850	METOJECT	1件: Methotrexate	1件: D00142	2件: DHFR, DHFR2 💬	5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬	6件: 41, 46, 96, 97, 107, 271
851	METRONIDAZOLE	1件: Metronidazole	1件: D00409	-	-	7件: 46, 51, 63, 94, 96, 97, 291
852	Metronidazole capsule 50 mg	1件: Metronidazole	1件: D00409	-	-	1件: 97
853	MEZAVANT	1件: Mesalazine	1件: D00377	-	-	1件: 97
854	Mezavant 1200 mg magensaftresistente Retardtabletten	1件: Mesalazine	1件: D00377	-	-	1件: 97
855	Mezavant Gastro-resistant, prolonged release tablets	2件: Manganese citrate, Mesalazine	1件: D00377	-	-	1件: 97
856	Mezavant XL	1件: Mesalazine	1件: D00377	-	-	1件: 97
857	Mezavant XL 1200 mg gastro-resistant prolonged release tablets	2件: Manganese citrate, Mesalazine	1件: D00377	-	-	1件: 97
858	Mezavant XL 1200 mg gastro-resistant, prolonged release tablets	2件: Manganese citrate, Mesalazine	1件: D00377	-	-	1件: 97
859	Mezavant XL 1200 mg gastro-resistant, prolonged release tablets.	2件: Manganese citrate, Mesalazine	1件: D00377	-	-	1件: 97
860	Mezavant XL 1200mg gastro-resistant, prolonged release tablets	2件: Manganese citrate, Mesalazine	1件: D00377	-	-	1件: 97
861	Mezavant XL Gastro-resistant, prolonged release tablets	2件: Manganese citrate, Mesalazine	1件: D00377	-	-	1件: 97
862	MH002	-	-	-	-	1件: 97
863	Microbiote fécal	-	-	-	-	1件: 97
864	Midazolam	1件: Midazolam	1件: D00550	16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬	7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬	12件: 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299
865	Mirikizumab	1件: Mirikizumab	1件: D11123	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	3件: 37, 96, 97
866	Mirikizumab IV	1件: Mirikizumab	1件: D11123	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	1件: 97
867	Mirikizumab SC	1件: Mirikizumab	1件: D11123	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	1件: 97
868	MitoQ	-	-	-	-	3件: 6, 13, 97
869	MK-6194	-	-	-	-	1件: 97
870	MK-8259	-	-	-	-	1件: 97
871	MLN0002	-	-	-	-	3件: 94, 96, 97
872	MLN0002 (Vedolizumab)	1件: Vedolizumab	1件: D08083	2件: ITGA4, ITGB7 💬	15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬	2件: 96, 97
873	MLN0002 SC	-	-	-	-	2件: 96, 97
874	MLN002	-	-	-	-	2件: 96, 97
875	MMX Mesalamine	1件: Mesalazine	1件: D00377	-	-	1件: 97
876	MMX mesalamine/ mesalazine	1件: Mesalazine	1件: D00377	-	-	1件: 97
877	MMX Mesalamine/Mesalazine	1件: Mesalazine	1件: D00377	-	-	1件: 97
878	MMX Mesalamine/Mesalazine (High Dose)	1件: Mesalazine	1件: D00377	-	-	1件: 97
879	MMX Mesalamine/Mesalazine (Low Dose)	1件: Mesalazine	1件: D00377	-	-	1件: 97
880	Modified Gegen Qinlian Decoction	-	-	-	-	1件: 97
881	Modified-release phosphatidylcholine	2件: Lecithin, Manganese citrate	1件: D04682	-	-	1件: 97
882	Molgramostim	1件: Molgramostim	1件: D05066	1件: CSF2RA 💬	4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬	3件: 97, 229, 299
883	Mongersen	1件: Mongersen	1件: D10956	1件: SMAD7 💬	2件: Hippo signaling pathway, TGF-beta signaling pathway 💬	2件: 96, 97
884	MONOCLONAL ANTIBODY ANTI-IGG1	-	-	-	-	3件: 37, 96, 97
885	MORF-057	-	-	-	-	1件: 97
886	MS-20 oral solution	-	-	-	-	1件: 97
887	MSC	-	-	-	-	6件: 6, 51, 60, 96, 97, 271
888	MT-1303	-	-	-	-	3件: 13, 96, 97
889	MTX	-	-	-	-	14件: 13, 35, 40, 46, 49, 50, 51, 60, 84, 96, 97, 107, 162, 271
890	MTX 12.5	-	-	-	-	1件: 97
891	MTX 25	-	-	-	-	1件: 97
892	Multiple dose- Group B	-	-	-	-	1件: 97
893	Multiple dose-Group B	-	-	-	-	1件: 97
894	MultiStem	1件: MultiStem	-	-	-	1件: 97
895	MultiStem high dose	1件: MultiStem	-	-	-	1件: 97
896	MultiStem low dose	1件: MultiStem	-	-	-	1件: 97
897	Mycodigest supplement	-	-	-	-	2件: 96, 97
898	MYRRH	1件: Myrrh	1件: D08948	-	-	1件: 97
899	Myrrhinil-Intest®	-	-	-	-	1件: 97
900	N.a.	-	-	-	-	10件: 3, 6, 8, 13, 46, 96, 97, 240, 256, 271
901	N.d.	-	-	-	-	1件: 97
902	Naltrexone	1件: Naltrexone	1件: D05113	3件: OPRD1, OPRK1, OPRM1 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬	12件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226
903	NAND (Neoandrographolide)	-	-	-	-	1件: 97
904	Nanocort	-	-	-	-	3件: 13, 46, 97
905	Nd	-	-	-	-	6件: 2, 6, 13, 46, 51, 97
906	Neomycin	1件: Neomycin	1件: D08260	-	-	3件: 96, 97, 296
907	Neoral	1件: Cyclosporine	1件: D00184	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬	3件: 60, 97, 222
908	Neoral Soft Gelatin Capsules	2件: Cyclosporine, Gelatin	3件: D00115 , D00184 , D06892	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬	2件: 97, 269
909	Niclosamide	1件: Niclosamide	1件: D00436	-	-	2件: 46, 97
910	Nicolon	-	-	-	-	1件: 97
911	Nicotinamide	1件: Nicotinamide	1件: D00036	-	-	8件: 2, 6, 18, 49, 97, 107, 162, 191
912	Nicotinamide riboside	2件: Nicotinamide, Nicotinamide riboside	1件: D00036	-	-	5件: 2, 6, 18, 97, 191
913	Nicotinamide Riboside Chloride	3件: Chloride ion, Nicotinamide, Nicotinamide riboside	1件: D00036	-	-	1件: 97
914	Nitazoxanide	1件: Nitazoxanide	1件: D02486	-	-	3件: 46, 96, 97
915	Nitazoxanide 500Mg Oral Tablet	1件: Nitazoxanide	1件: D02486	-	-	2件: 46, 97
916	Nivolumab	1件: Nivolumab	1件: D10316	1件: PDCD1 💬	3件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬	12件: 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159
917	NO	-	-	-	-	9件: 6, 46, 58, 62, 86, 97, 222, 299, 321
918	Nolpitantium Besylate	-	-	-	-	1件: 97
919	Non as of yet	-	-	-	-	1件: 97
920	None	-	-	-	-	20件: 6, 46, 51, 65, 66, 78, 84, 85, 96, 97, 140, 160, 161, 171, 222, 231, 246, 271, 299, 337
921	None given	1件: Interleukin-1 alpha, human recombinant	-	-	-	1件: 97
922	Normal Saline Enema	-	-	-	-	1件: 97
923	Null	-	-	-	-	16件: 6, 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271
924	Nutrition supplement	-	-	-	-	1件: 97
925	Nutritional dietary intervention	-	-	-	-	2件: 96, 97
926	Nuvion®)	-	-	-	-	1件: 97
927	NX-13 250 mg	-	-	-	-	1件: 97
928	NX-13 250mg IR	-	-	-	-	1件: 97
929	NX-13 500mg IR	-	-	-	-	1件: 97
930	NX-13 500mg MR	-	-	-	-	1件: 97
931	Oats	1件: Oat	-	-	-	1件: 97
932	Obefazimod	-	-	-	-	1件: 97
933	Omeprazole	1件: Omeprazole	1件: D00455	2件: ATP4A, ATP4B 💬	4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬	14件: 6, 8, 21, 46, 51, 85, 96, 97, 225, 271, 282, 294, 298, 299
934	Ondansetron	1件: Ondansetron	1件: D00456	5件: HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬	2件: Serotonergic synapse, Taste transduction 💬	3件: 6, 97, 107
935	Ondansetron hydrochloride dihydrate	1件: Ondansetron	1件: D00456	5件: HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬	2件: Serotonergic synapse, Taste transduction 💬	2件: 6, 97
936	Ontamalimab	1件: Ontamalimab	-	-	-	2件: 96, 97
937	OPC-6535	-	-	-	-	2件: 96, 97
938	OPC-6535 Tablets (drug)	-	-	-	-	1件: 97
939	OPC-6535(Tetomilast)	1件: Tetomilast	-	-	-	2件: 96, 97
940	OPRX-106	-	-	-	-	1件: 97
941	OPRX-106 (plant cells expressing TNFR-Fc) 2mg	-	-	-	-	1件: 97
942	OPRX-106 (plant cells expressing TNFR-Fc) 8mg	-	-	-	-	1件: 97
943	Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone	2件: Mesalazine, Methylprednisolone	2件: D00377 , D00407	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
944	Oral corticosteroids	-	-	-	-	5件: 13, 46, 97, 171, 251
945	Oral Iron	1件: Iron	-	-	-	2件: 97, 254
946	Oral OKT3	-	-	-	-	1件: 97
947	ORE1001	-	-	-	-	1件: 97
948	ORENCIA	1件: Abatacept	1件: D03203	2件: CD80, CD86 💬	13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬	14件: 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 160, 222, 271
949	Originator (legacy) drug	-	-	-	-	4件: 46, 96, 97, 271
950	OSE-127	-	-	-	-	2件: 53, 97
951	Oseltamivir	1件: Oseltamivir	1件: D08306	-	-	2件: 97, 299
952	OST-122	-	-	-	-	1件: 97
953	Other Biologic Therapies	-	-	-	-	2件: 96, 97
954	Overencapsulated Azathioprine (Imuran) 50 mg Tablet	1件: Azathioprine	1件: D00238	-	-	1件: 97
955	Overencapsulated mesalazine tablets	1件: Mesalazine	1件: D00377	-	-	1件: 97
956	Ozanimod	1件: Ozanimod	1件: D10968	5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬	3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬	3件: 13, 96, 97
957	Ozanimod HCL	1件: Ozanimod	1件: D10968	5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬	3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬	2件: 13, 97
958	Ozanimod hydrochloride	1件: Ozanimod	1件: D10968	5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬	3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬	3件: 13, 96, 97
959	Palmitoleic Acid	1件: Palmitoleic Acid	-	-	-	1件: 97
960	Parnaparin	1件: Parnaparin	1件: D07510	1件: SERPINC1 💬	1件: Complement and coagulation cascades 💬	1件: 97
961	PARNAPARIN SODIUM	1件: Parnaparin	1件: D07510	1件: SERPINC1 💬	1件: Complement and coagulation cascades 💬	1件: 97
962	PBF-677	-	-	-	-	1件: 97
963	PCT (PureCell Technologies Complex)	-	-	-	-	1件: 97
964	PEG	-	-	-	-	15件: 6, 13, 41, 46, 60, 65, 78, 96, 97, 140, 144, 240, 246, 299, 337
965	PEG-liposomal Prednisolone Sodium Phosphate	2件: Phosphate ion, Prednisolone	1件: D00472	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	2件: 13, 97
966	Pending	-	-	-	-	6件: 13, 19, 96, 97, 113, 302
967	Pentasa	1件: Mesalazine	1件: D00377	-	-	2件: 96, 97
968	Pentasa 2g sachet prolonged release granules (95%)	2件: Manganese citrate, Mesalazine	1件: D00377	-	-	1件: 97
969	Pentasa 500 mg Retardtabletten	1件: Mesalazine	1件: D00377	-	-	1件: 97
970	Pentasa Compact 2g, granulate with prolonged release	2件: Manganese citrate, Mesalazine	1件: D00377	-	-	1件: 97
971	Pentasa Compact 4g, granulate with prolonged release	2件: Manganese citrate, Mesalazine	1件: D00377	-	-	1件: 97
972	Pentasa enema	1件: Mesalazine	1件: D00377	-	-	1件: 97
973	Pentasa prolonged release granules 2g	2件: Manganese citrate, Mesalazine	1件: D00377	-	-	1件: 97
974	PENTASA Sachet	1件: Mesalazine	1件: D00377	-	-	2件: 96, 97
975	Pentasa Sachet 1 g	1件: Mesalazine	1件: D00377	-	-	2件: 96, 97
976	Pentasa Sachet 1g	1件: Mesalazine	1件: D00377	-	-	1件: 97
977	Pentasa Sachet 2 g	1件: Mesalazine	1件: D00377	-	-	1件: 97
978	Pentoxifylline	1件: Pentoxifylline	1件: D00501	-	-	12件: 26, 56, 84, 86, 93, 96, 97, 113, 220, 222, 296, 298
979	Pentoxifylline 400 MG	1件: Pentoxifylline	1件: D00501	-	-	1件: 97
980	PF 06687234	-	-	-	-	2件: 96, 97
981	PF-00547659	-	-	-	-	2件: 96, 97
982	PF-00547659 SC injection	-	-	-	-	2件: 96, 97
983	PF-05230917	-	-	-	-	1件: 97
984	PF-05285401	-	-	-	-	1件: 97
985	PF-06480605	-	-	-	-	1件: 97
986	PF-06480605 100 mg/ml	-	-	-	-	1件: 97
987	PF-06651600	1件: PF-06651600	-	-	-	3件: 46, 96, 97
988	PF-06651600 10 mg	1件: PF-06651600	-	-	-	1件: 97
989	PF-06651600 50 mg	1件: PF-06651600	-	-	-	2件: 96, 97
990	PF-06651600-15	1件: PF-06651600	-	-	-	2件: 96, 97
991	PF-06687234	-	-	-	-	1件: 97
992	PF-06700841	1件: PF-06700841	-	-	-	3件: 49, 96, 97
993	PF-06700841 25 mg	1件: PF-06700841	-	-	-	2件: 96, 97
994	PF-06700841 5 mg	1件: PF-06700841	-	-	-	3件: 49, 96, 97
995	PF-06700841-15	1件: PF-06700841	-	-	-	3件: 49, 96, 97
996	PF-06826647	-	-	-	-	1件: 97
997	PF-06826647 100 mg QD	-	-	-	-	1件: 97
998	PF-06826647 300 mg QD	-	-	-	-	1件: 97
999	PF-06826647 600 mg QD	-	-	-	-	1件: 97
1000	PF-07054894	-	-	-	-	1件: 97
1001	PF-6826647 400 mg QD	-	-	-	-	1件: 97
1002	Pfefferminzblätter 1ml/10ml	-	-	-	-	1件: 97
1003	PGx-guided post-operative pain management	-	-	-	-	2件: 96, 97
1004	Phentermine	1件: Phentermine	1件: D05458	5件: MAOA, MAOB, SLC6A2, SLC6A3, SLC6A4 💬	16件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Phenylalanine metabolism, Serotonergic synapse, Synaptic vesicle cycle, Tryptophan metabolism, Tyrosine metabolism 💬	1件: 97
1005	Phentermine-Topiramate	2件: Phentermine, Topiramate	2件: D00537 , D05458	41件: CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, MAOA, MAOB, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SLC6A2, SLC6A3, SLC6A4 💬	63件: Adrenergic signaling in cardiomyocytes, Alcoholism, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arginine and proline metabolism, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, Drug metabolism - cytochrome P450, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, Glycine, serine and threonine metabolism, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Histidine metabolism, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Phenylalanine metabolism, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Synaptic vesicle cycle, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Tryptophan metabolism, Type II diabetes mellitus, Tyrosine metabolism, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 97
1006	Phosphate	1件: Phosphate ion	-	-	-	32件: 2, 3, 6, 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299
1007	Phosphatidylcholine	1件: Lecithin	1件: D04682	-	-	1件: 97
1008	Photodynamic therapy with Gliolan	1件: Aminolevulinic acid	1件: D07567	-	-	1件: 97
1009	Picosulfate	1件: Picosulfuric acid	-	-	-	2件: 97, 291
1010	PL8177	-	-	-	-	1件: 97
1011	Placebo	-	-	-	-	28件: 3, 5, 6, 11, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276
1012	PN-10884A	-	-	-	-	1件: 97
1013	PN-943	-	-	-	-	1件: 97
1014	Polaprezinc	1件: Polaprezinc	1件: D01611	-	-	2件: 96, 97
1015	Polyethylene glycol	1件: Polyethylene glycol	1件: D03370	-	-	7件: 6, 78, 96, 97, 235, 276, 299
1016	Polyphenon E®	-	-	-	-	1件: 97
1017	PRA023	-	-	-	-	3件: 51, 96, 97
1018	PRA023 IV	-	-	-	-	3件: 51, 96, 97
1019	PRD5973697	-	-	-	-	1件: 97
1020	Prebiotics	-	-	-	-	2件: 96, 97
1021	Prednisolon	-	-	-	-	7件: 46, 50, 51, 66, 95, 96, 97
1022	Prednisolon Jenapharm	-	-	-	-	2件: 96, 97
1023	PREDNISOLONE	1件: Prednisolone	1件: D00472	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	42件: 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300
1024	Prednisolone sodium metasulphobenzoate	1件: Prednisolone	1件: D00472	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
1025	PREDNISOLONE SODIUM PHOSPHATE	2件: Phosphate ion, Prednisolone	1件: D00472	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	3件: 3, 13, 97
1026	Prednisolone Tablets B.P. 5mg	1件: Prednisolone	1件: D00472	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
1027	Prednisone	1件: Prednisone	1件: D00473	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	45件: 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331
1028	Prefilled Syringe delivery of Golimumab	1件: Golimumab	1件: D04358	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
1029	Previously referred to as MEDI2070 and AMG 139	-	-	-	-	2件: 96, 97
1030	PRIM-DJ2727	-	-	-	-	2件: 6, 97
1031	PRO145223	-	-	-	-	1件: 97
1032	PRO145223 (RO5490261)	-	-	-	-	1件: 97
1033	Probiotic	-	-	-	-	8件: 2, 6, 93, 96, 97, 193, 266, 299
1034	Probiotic Formula Capsule	-	-	-	-	1件: 97
1035	Probiotic Mixture	-	-	-	-	2件: 96, 97
1036	Probiotics	-	-	-	-	5件: 6, 94, 96, 97, 291
1037	Products containing aminosalicylate	-	-	-	-	1件: 97
1038	Products containing azathioprine or 6-mercaptopurine	2件: Azathioprine, Mercaptopurine	3件: D00161 , D00238 , D04931	1件: HPRT1 💬	4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬	1件: 97
1039	Proline	1件: Proline	1件: D00035	-	-	2件: 94, 97
1040	Promiten	-	-	-	-	1件: 97
1041	PROPIONYL L-CARNITINE	1件: Levocarnitine	1件: D02176	-	-	1件: 97
1042	PROPIONYL L-CARNITINE HYDROCHLORIDE	1件: Levocarnitine	1件: D02176	-	-	1件: 97
1043	Propionyl-L-Carnitine	2件: Levocarnitine, Levocarnitine propionate	1件: D02176	-	-	1件: 97
1044	Propionylcarnitinhydrochlorid	-	-	-	-	1件: 97
1045	PRV-300	-	-	-	-	1件: 97
1046	PS	-	-	-	-	2件: 90, 97
1047	PS-QD	-	-	-	-	1件: 97
1048	PS-SP	-	-	-	-	1件: 97
1049	Psyllium	1件: Plantago seed	1件: D05525	-	-	3件: 6, 28, 97
1050	Psyllium husk	1件: Plantago seed	1件: D05525	-	-	1件: 97
1051	Psyllium Husk Powder	1件: Plantago seed	1件: D05525	-	-	1件: 97
1052	PTG-100	-	-	-	-	1件: 97
1053	PUR 0110	-	-	-	-	1件: 97
1054	PUR 0110 Rectal Enema	-	-	-	-	1件: 97
1055	PUR 0110 Rectal Enema 1000 mg	-	-	-	-	1件: 97
1056	PUR 0110 Rectal Enema 250 mg	-	-	-	-	1件: 97
1057	PUR 0110 Rectal Enema 500 mg	-	-	-	-	1件: 97
1058	Puri-Nethol	-	-	-	-	3件: 86, 96, 97
1059	PV	-	-	-	-	1件: 97
1060	Pyrrolidine	1件: Pyrrolidine	-	-	-	2件: 28, 97
1061	QBECO SSI	-	-	-	-	1件: 97
1062	R-3750	-	-	-	-	1件: 97
1063	Raspberry	1件: Raspberry	1件: D09179	-	-	1件: 97
1064	Ravagalimab	1件: Ravagalimab	1件: D11597	1件: CD40 💬	17件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis 💬	2件: 53, 97
1065	RDP58	-	-	-	-	1件: 97
1066	Rebamipide	1件: Rebamipide	1件: D01121	-	-	4件: 46, 53, 97, 271
1067	Recombinant Factor XIII (rFXIII)	1件: Factor XIII (human)	-	-	-	2件: 97, 288
1068	RECTABUL2mg rectal form	-	-	-	-	1件: 97
1069	Rectal dialysis	-	-	-	-	1件: 97
1070	Rectal tacrolimus	1件: Tacrolimus	2件: D00107 , D08556	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬	1件: 97
1071	Regular treatment	-	-	-	-	1件: 97
1072	Regulatory T cells	-	-	-	-	2件: 95, 97
1073	Release	1件: Manganese citrate	-	-	-	12件: 6, 8, 13, 46, 65, 78, 81, 96, 97, 206, 226, 299
1074	Remestemcel-L	1件: Remestemcel-L	1件: D09719	-	-	2件: 96, 97
1075	Remicade	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	9件: 40, 46, 49, 56, 84, 85, 96, 97, 271
1076	REMICADE (INFLIXIMAB)	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	3件: 46, 96, 97
1077	Remicade 100 mg infuusiokuiva-aine, konsentraattiliuosta varten	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
1078	Remicade 100 mg powder for concentrate for solution for infusion.	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	2件: 96, 97
1079	Remicade 100 mg pulver til konsentrat til infusjonsvæske, oppløsning	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	4件: 46, 96, 97, 271
1080	REMSIMA	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	4件: 46, 96, 97, 271
1081	Remsima (CT-P13)	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
1082	Remsima (infliximab)	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	3件: 46, 96, 97
1083	REMSIMA - 100 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLANCONCINO (VETRO) - 1 FLACONCINO	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	4件: 46, 96, 97, 271
1084	Remsima 100 mg pulver til konsentrat til infusjonsvæske, oppløsning	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	4件: 46, 96, 97, 271
1085	Remsima and Inflectra	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	2件: 96, 97
1086	Repomol	-	-	-	-	1件: 97
1087	Resveratrol	1件: Resveratrol	-	-	-	6件: 2, 8, 18, 89, 97, 113
1088	Resveratrol Supplementation	1件: Resveratrol	-	-	-	1件: 97
1089	Retarded release phosphatidylcholine	1件: Lecithin	1件: D04682	-	-	1件: 97
1090	Retarded Release Phosphatidylcholine (rPC)	1件: Lecithin	1件: D04682	-	-	1件: 97
1091	RhIL-11	-	-	-	-	1件: 97
1092	RhuMAb Beta7	-	-	-	-	1件: 97
1093	RhuMAb Beta7, Anti Beta 7, PRO145223	-	-	-	-	1件: 97
1094	RhuMAb Beta7, Anti Beta7, PRO145223	-	-	-	-	1件: 97
1095	Riboflavin	1件: Riboflavin	1件: D00050	-	-	7件: 38, 46, 96, 97, 162, 168, 265
1096	Rifaximin	1件: Rifaximin	1件: D02554	-	-	8件: 6, 65, 93, 96, 97, 99, 296, 299
1097	Risankizumab	1件: Risankizumab	1件: D11052	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	4件: 37, 96, 97, 271
1098	Risankizumab (Genetical Recombination)	1件: Risankizumab	1件: D11052	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	1件: 97
1099	Risankizumab IV	1件: Risankizumab	1件: D11052	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	2件: 96, 97
1100	Risankizumab SC	1件: Risankizumab	1件: D11052	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	2件: 96, 97
1101	Ritlecitinib	-	-	-	-	1件: 97
1102	Ritlecitinib 10 mg	-	-	-	-	1件: 97
1103	Ritlecitinib 5 mg	-	-	-	-	1件: 97
1104	Ritlecitinib 50 mg	-	-	-	-	2件: 96, 97
1105	RITUXIMAB	1件: Rituximab	1件: D02994	1件: MS4A1 💬	1件: Hematopoietic cell lineage 💬	48件: 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331
1106	Rivenprost	1件: Rivenprost	-	-	-	1件: 97
1107	Rivenprost (drug)	1件: Rivenprost	-	-	-	1件: 97
1108	Ro 549-0261/F04	-	-	-	-	1件: 97
1109	RO5490261 / F02	-	-	-	-	1件: 97
1110	RO5490261/F02	-	-	-	-	1件: 97
1111	RO5490261/F04-02	-	-	-	-	1件: 97
1112	RO7021610	-	-	-	-	1件: 97
1113	RO7049665	-	-	-	-	2件: 95, 97
1114	RO7246311	-	-	-	-	1件: 97
1115	Roflumilast	1件: Roflumilast	1件: D05744	4件: PDE4A, PDE4B, PDE4C, PDE4D 💬	5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬	4件: 84, 97, 206, 299
1116	Roflumilast 500 Ug ORAL TABLET [Daliresp]	1件: Roflumilast	1件: D05744	4件: PDE4A, PDE4B, PDE4C, PDE4D 💬	5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬	1件: 97
1117	Rosiglitazone	1件: Rosiglitazone	1件: D08491	1件: PPARG 💬	11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬	5件: 46, 75, 97, 222, 265
1118	Rosuvastatin	1件: Rosuvastatin	1件: D08492	1件: HMGCR 💬	4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬	11件: 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299
1119	Rosuvastatin 10mg	1件: Rosuvastatin	1件: D08492	1件: HMGCR 💬	4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬	1件: 97
1120	ROSUVASTATIN CALCIUM	2件: Calcium, Rosuvastatin	1件: D08492	1件: HMGCR 💬	4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬	4件: 49, 79, 97, 299
1121	Rosuvastatine EG	-	-	-	-	1件: 97
1122	RPC1063	-	-	-	-	3件: 13, 96, 97
1123	RTNV148B IgG	-	-	-	-	3件: 46, 97, 271
1124	Saffron	-	-	-	-	1件: 97
1125	Saffron 100	-	-	-	-	1件: 97
1126	Saffron 50	-	-	-	-	1件: 97
1127	Saffron supplement for IBD	-	-	-	-	1件: 97
1128	Salicylic acid	1件: Salicylic acid	1件: D00097	-	-	1件: 97
1129	Saline	-	-	-	-	10件: 6, 13, 17, 53, 67, 78, 86, 97, 168, 299
1130	Salmon	1件: Salmon, unspecified	-	-	-	3件: 96, 97, 225
1131	Salofalk	1件: Mesalazine	1件: D00377	-	-	2件: 96, 97
1132	Salofalk 1000mg Granu-Stix	1件: Mesalazine	1件: D00377	-	-	1件: 97
1133	Salofalk 1000mg Granu-Stix®	1件: Mesalazine	1件: D00377	-	-	1件: 97
1134	Salofalk 3g gastro-resistant prolonged-release granules	2件: Manganese citrate, Mesalazine	1件: D00377	-	-	1件: 97
1135	Salofalk 4g/60ml Klysma	1件: Mesalazine	1件: D00377	-	-	1件: 97
1136	Salofalk Granu-Stix 500 mg	1件: Mesalazine	1件: D00377	-	-	1件: 97
1137	Salofalk® 1000mg Granu-Stix®	1件: Mesalazine	1件: D00377	-	-	1件: 97
1138	Salofalk® 500 mg gastro-resistant tablet	1件: Mesalazine	1件: D00377	-	-	1件: 97
1139	Salofalk® 500 mg tablets	1件: Mesalazine	1件: D00377	-	-	1件: 97
1140	Salofalk® 500mg	1件: Mesalazine	1件: D00377	-	-	1件: 97
1141	Salofalk® 500mg Granu-Stix®	1件: Mesalazine	1件: D00377	-	-	1件: 97
1142	Sandimmum	-	-	-	-	1件: 97
1143	Sandimmun	-	-	-	-	2件: 97, 226
1144	Sandimmun 50 mg/ml, infuusiokonsentraatti	-	-	-	-	1件: 97
1145	Sandimmun Neoral	1件: Cyclosporine	1件: D00184	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬	3件: 60, 97, 226
1146	SANDINUM	-	-	-	-	1件: 97
1147	SAR339658	-	-	-	-	2件: 13, 97
1148	SAR443122	-	-	-	-	1件: 97
1149	SB-656933	-	-	-	-	1件: 97
1150	SB-656933 Tablets	-	-	-	-	2件: 97, 299
1151	SB012	-	-	-	-	1件: 97
1152	SB5	-	-	-	-	5件: 46, 96, 97, 107, 271
1153	SC12267	1件: SC12267	-	-	-	3件: 46, 96, 97
1154	SC12267 (4SC-101)	1件: SC12267	-	-	-	3件: 46, 96, 97
1155	SCH 900050	-	-	-	-	1件: 97
1156	Semi-vegetarian diet	-	-	-	-	1件: 97
1157	SER-287	-	-	-	-	1件: 97
1158	SF257 C59	-	-	-	-	1件: 97
1159	Shingrix	1件: Varicella zoster vaccine (recombinant)	-	-	-	3件: 46, 96, 97
1160	SHP647	-	-	-	-	2件: 96, 97
1161	SHR0302	-	-	-	-	4件: 46, 96, 97, 271
1162	SHR0302 Tablets	-	-	-	-	2件: 46, 97
1163	SIMPONI	1件: Golimumab	1件: D04358	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	3件: 46, 97, 271
1164	Simponi (Golimumab)	1件: Golimumab	1件: D04358	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
1165	Simponi®	1件: Golimumab	1件: D04358	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	3件: 46, 97, 271
1166	Simponi® (Golimumab)	1件: Golimumab	1件: D04358	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
1167	Simulect	1件: Basiliximab	1件: D03058	1件: IL2RA 💬	11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬	2件: 66, 97
1168	Single dose-group A	-	-	-	-	1件: 97
1169	Smartject Device delivery of Golimumab	1件: Golimumab	1件: D04358	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	1件: 97
1170	Smoking cigarettes	-	-	-	-	2件: 96, 97
1171	Smoking of cannabis	1件: Medical Cannabis	-	-	-	2件: 96, 97
1172	Sodium (S)-3-(4-hydroxyphenyl)-2-(2-((S)-1-((S)-1-palmitoylpyrrolidine-2-carbonyl)pyrrolidine-2-carboxamido)acetamido)propanoate	1件: Pyrrolidine	-	-	-	1件: 97
1173	Sodium hyaluronate	1件: Hyaluronic acid	1件: D08043	-	-	2件: 53, 97
1174	Sodium Picosulfate/Magnesium Citrate Laxative	4件: Magnesium, Magnesium citrate, Picosulfuric acid, Polyethylene glycol	2件: D03265 , D03370	-	-	1件: 97
1175	Solu-Medrol	1件: Methylprednisolone hemisuccinate	1件: D05000	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	7件: 13, 49, 50, 51, 53, 97, 211
1176	Sotrastaurin	1件: Sotrastaurin	1件: D09671	4件: PRKCD, PRKCE, PRKCH, PRKCQ 💬	29件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Aldosterone synthesis and secretion, Apelin signaling pathway, Autophagy - animal, C-type lectin receptor signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemokine signaling pathway, Diabetic cardiomyopathy, Estrogen signaling pathway, Fc gamma R-mediated phagocytosis, GnRH signaling pathway, Inflammatory mediator regulation of TRP channels, Insulin resistance, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Prion disease, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	1件: 97
1177	Sotrastaurin (INN) acetate	2件: Acetate, Sotrastaurin	1件: D09671	4件: PRKCD, PRKCE, PRKCH, PRKCQ 💬	29件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Aldosterone synthesis and secretion, Apelin signaling pathway, Autophagy - animal, C-type lectin receptor signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemokine signaling pathway, Diabetic cardiomyopathy, Estrogen signaling pathway, Fc gamma R-mediated phagocytosis, GnRH signaling pathway, Inflammatory mediator regulation of TRP channels, Insulin resistance, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Prion disease, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	1件: 97
1178	Soybean	1件: Soybean	-	-	-	1件: 97
1179	SOYBEAN PHOSPHATIDYLCHOLINE	2件: Lecithin, Soybean	1件: D04682	-	-	1件: 97
1180	SPD476	-	-	-	-	1件: 97
1181	SPD476 (mesalazine)	1件: Mesalazine	1件: D00377	-	-	1件: 97
1182	SPD476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine	1件: Mesalazine	1件: D00377	-	-	1件: 97
1183	Spesolimab	1件: Spesolimab	1件: D12066	1件: IL1RL2 💬	1件: Cytokine-cytokine receptor interaction 💬	3件: 37, 96, 97
1184	Spesolimab IV infusion	1件: Spesolimab	1件: D12066	1件: IL1RL2 💬	1件: Cytokine-cytokine receptor interaction 💬	1件: 97
1185	Spesolimab SC solution for injection	1件: Spesolimab	1件: D12066	1件: IL1RL2 💬	1件: Cytokine-cytokine receptor interaction 💬	1件: 97
1186	SPH3127	-	-	-	-	1件: 97
1187	SPH3127 Tablets with Dose A	-	-	-	-	1件: 97
1188	SPH3127 Tablets with Dose B	-	-	-	-	1件: 97
1189	SR140333B	-	-	-	-	1件: 97
1190	SRT2104	-	-	-	-	1件: 97
1191	ST 261	-	-	-	-	1件: 97
1192	ST-0529	-	-	-	-	1件: 97
1193	ST10-021	-	-	-	-	2件: 96, 97
1194	ST261	-	-	-	-	1件: 97
1195	Standard 2 hours-infusion	-	-	-	-	2件: 96, 97
1196	Standard therapy	-	-	-	-	2件: 49, 97
1197	Standardized anthocyanin-rich extract	-	-	-	-	1件: 97
1198	Standardized FODMAP	-	-	-	-	1件: 97
1199	Stasis	1件: Ferric sulfate	1件: D08922	-	-	2件: 66, 97
1200	Stelara	1件: Ustekinumab	1件: D09214	3件: IL12A, IL12B, IL23A 💬	28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬	6件: 49, 56, 96, 97, 269, 271
1201	STELARA - 90 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 1.0 ML (90 MG/ML) 1 FLACONCINO	1件: Ustekinumab	1件: D09214	3件: IL12A, IL12B, IL23A 💬	28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬	2件: 96, 97
1202	STELARA®	1件: Ustekinumab	1件: D09214	3件: IL12A, IL12B, IL23A 💬	28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬	3件: 49, 96, 97
1203	Sterile saline for injection	-	-	-	-	1件: 97
1204	Steroids	-	-	-	-	7件: 46, 50, 51, 63, 66, 96, 97
1205	STNM01	-	-	-	-	1件: 97
1206	STNM01 1.84 mg	-	-	-	-	1件: 97
1207	STW5-II	-	-	-	-	1件: 97
1208	STW5-II (Iberogast N, BAY98-7410)	-	-	-	-	1件: 97
1209	Sucrose	1件: Sucrose	1件: D00025	-	-	3件: 62, 96, 97
1210	Sucrosomial Iron	1件: Iron	-	-	-	1件: 97
1211	Sugar Extract	-	-	-	-	2件: 96, 97
1212	Sulphsalazine, Pentasa, Asacol, Colazide, Depentum	-	-	-	-	1件: 97
1213	SUSPENSION CONTAINING 7500 EMBRYONATED VIABLE TRICHURIS SUIS OVA/15ML	-	-	-	-	1件: 97
1214	Suspension de microbiote fécal	-	-	-	-	1件: 97
1215	Synergy-1	-	-	-	-	1件: 97
1216	Synergy1	-	-	-	-	1件: 97
1217	Sübetaholzwurzel 1ml/10ml	-	-	-	-	1件: 97
1218	Süßholzwurzel 1ml/10ml	-	-	-	-	1件: 97
1219	TA-650	-	-	-	-	4件: 37, 56, 96, 97
1220	TA-650 (Infliximab)	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	3件: 46, 97, 271
1221	Tacrolimus	1件: Tacrolimus	2件: D00107 , D08556	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬	34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
1222	Tauroursoursodeoxycholic acid, brand name Tudcabil	-	-	-	-	1件: 97
1223	TD-1473	-	-	-	-	2件: 96, 97
1224	TD-1473 Dose A	-	-	-	-	1件: 97
1225	TD-1473 Dose B	-	-	-	-	1件: 97
1226	TD-1473 Dose C	-	-	-	-	1件: 97
1227	TD-3504	-	-	-	-	1件: 97
1228	Telotristat	1件: Telotristat	1件: D09973	2件: TPH1, TPH2 💬	4件: Folate biosynthesis, Metabolic pathways, Serotonergic synapse, Tryptophan metabolism 💬	1件: 97
1229	Telotristat Etiprate	1件: Telotristat	1件: D09973	2件: TPH1, TPH2 💬	4件: Folate biosynthesis, Metabolic pathways, Serotonergic synapse, Tryptophan metabolism 💬	1件: 97
1230	Terbinafine	1件: Terbinafine	1件: D02375	-	-	3件: 96, 97, 271
1231	Tetomilast	1件: Tetomilast	-	-	-	2件: 96, 97
1232	Tetracycline	1件: Tetracycline	1件: D00201	-	-	4件: 13, 46, 53, 97
1233	TEV-48574	-	-	-	-	2件: 96, 97
1234	TEV-48574 Dose Regimen A	-	-	-	-	2件: 96, 97
1235	TEV-48574 Dose Regiment B	-	-	-	-	2件: 96, 97
1236	Thalidomide	1件: Thalidomide	1件: D00754	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	20件: 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331
1237	Thalidomide Pharmion	1件: Thalidomide	1件: D00754	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	3件: 85, 96, 97
1238	Threonine	1件: Threonine	1件: D00041	-	-	2件: 86, 97
1239	THRX-139060	-	-	-	-	2件: 96, 97
1240	Tilpisertib	-	-	-	-	1件: 97
1241	TJ301 300mg	-	-	-	-	1件: 97
1242	TJ301 600mg	-	-	-	-	1件: 97
1243	TLL018	-	-	-	-	1件: 97
1244	TNF Inhibitor	-	-	-	-	2件: 46, 97
1245	To be confirmed	-	-	-	-	3件: 46, 65, 97
1246	To be requested	-	-	-	-	2件: 96, 97
1247	TOFACINITIB	-	-	-	-	1件: 97
1248	Tofacitinib	1件: Tofacitinib	1件: D09970	4件: JAK1, JAK2, JAK3, TYK2 💬	37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬	15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300
1249	Tofacitinib 10 MG [Xeljanz]	1件: Tofacitinib	1件: D09970	4件: JAK1, JAK2, JAK3, TYK2 💬	37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬	1件: 97
1250	TOFACITINIB CITRATE	1件: Tofacitinib	1件: D09970	4件: JAK1, JAK2, JAK3, TYK2 💬	37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬	5件: 46, 49, 97, 107, 271
1251	Tofacitinib citrate (clinical trial image)	1件: Tofacitinib	1件: D09970	4件: JAK1, JAK2, JAK3, TYK2 💬	37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬	2件: 46, 97
1252	Tofacitinib citrate (Phase III formulation)	1件: Tofacitinib	1件: D09970	4件: JAK1, JAK2, JAK3, TYK2 💬	37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬	2件: 46, 97
1253	Tofacitinib citrate (Proposed commercial formulation - debossed)	1件: Tofacitinib	1件: D09970	4件: JAK1, JAK2, JAK3, TYK2 💬	37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬	2件: 46, 97
1254	Tofacitinib citrate (Proposed commercial formulation – debossed)	1件: Tofacitinib	1件: D09970	4件: JAK1, JAK2, JAK3, TYK2 💬	37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬	2件: 46, 97
1255	Tofacitinib citrate (Proposed commercialFormulation - debossed)	1件: Tofacitinib	1件: D09970	4件: JAK1, JAK2, JAK3, TYK2 💬	37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬	1件: 97
1256	Top down treatment if patient at high risk	-	-	-	-	2件: 96, 97
1257	TOP1288	-	-	-	-	1件: 97
1258	TOP1288 Rectal solution	-	-	-	-	1件: 97
1259	TOPIRAMATE	1件: Topiramate	1件: D00537	36件: CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	53件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	6件: 6, 97, 140, 144, 156, 193
1260	TP05	-	-	-	-	1件: 97
1261	TP05 Coating A	-	-	-	-	1件: 97
1262	TP05 Coating B	-	-	-	-	1件: 97
1263	TP05 Coating D	-	-	-	-	1件: 97
1264	TP05 Coating E	-	-	-	-	1件: 97
1265	TP05 Coating H	-	-	-	-	1件: 97
1266	TPMT genotyping	-	-	-	-	2件: 96, 97
1267	Traditional treatments	-	-	-	-	1件: 97
1268	Tralokinumab	1件: Tralokinumab	1件: D09979	1件: IL13 💬	8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬	2件: 85, 97
1269	Treatment Algorithm A	-	-	-	-	1件: 97
1270	Treatment Algorithm B	-	-	-	-	1件: 97
1271	Treatment Algorithm C	-	-	-	-	1件: 97
1272	Treatment vs control bread	-	-	-	-	1件: 97
1273	TREMFYA	1件: Guselkumab	1件: D10438	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	2件: 37, 97
1274	TREMFYA®	1件: Guselkumab	1件: D10438	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	2件: 37, 97
1275	Trexan	-	-	-	-	2件: 46, 97
1276	Trexan inj 25 mg/ml	-	-	-	-	1件: 97
1277	Trichuris suis eggs	-	-	-	-	3件: 13, 96, 97
1278	Trichuris suis Ova	-	-	-	-	4件: 13, 46, 96, 97
1279	Trichuris suis ova (TSO)	-	-	-	-	2件: 96, 97
1280	Tris	1件: Tromethamine	1件: D00396	-	-	2件: 96, 97
1281	TSO	-	-	-	-	3件: 13, 46, 97
1282	TYK2 Inhibitor	-	-	-	-	1件: 97
1283	UCB4940	-	-	-	-	3件: 46, 97, 271
1284	UCMSC group	-	-	-	-	1件: 97
1285	UDCA	1件: Ursodeoxycholic acid	1件: D00734	1件: NR1H4 💬	1件: Bile secretion 💬	6件: 46, 67, 93, 94, 97, 296
1286	Umbilical cord blood mononuclear cells	-	-	-	-	1件: 97
1287	Umbilical cord mesenchymal stem cells	-	-	-	-	5件: 13, 46, 57, 97, 113
1288	Unknown	-	-	-	-	3件: 34, 67, 97
1289	Upadacitinib	1件: Upadacitinib	1件: D10994	1件: JAK1 💬	27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬	8件: 40, 41, 46, 49, 96, 97, 107, 271
1290	Upadacitinib (ABT-494)	1件: Upadacitinib	1件: D10994	1件: JAK1 💬	27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬	1件: 97
1291	Upadacitinib - Direct compression-yellow	1件: Upadacitinib	1件: D10994	1件: JAK1 💬	27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬	1件: 97
1292	Upadacitinib -Direct compression-yellow	1件: Upadacitinib	1件: D10994	1件: JAK1 💬	27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬	1件: 97
1293	Updacitinib (ABT-494)	-	-	-	-	1件: 97
1294	UR-12746-S	-	-	-	-	1件: 97
1295	Urbason	-	-	-	-	3件: 13, 97, 222
1296	Ursodeoxycholic acid	1件: Ursodeoxycholic acid	1件: D00734	1件: NR1H4 💬	1件: Bile secretion 💬	10件: 6, 46, 67, 84, 93, 94, 95, 96, 97, 296
1297	Ursodiol	1件: Ursodeoxycholic acid	1件: D00734	1件: NR1H4 💬	1件: Bile secretion 💬	6件: 8, 20, 93, 97, 234, 299
1298	Ursodiol (ursodeoxycholic acid, UDCA)	1件: Ursodeoxycholic acid	1件: D00734	1件: NR1H4 💬	1件: Bile secretion 💬	1件: 97
1299	Ursofalk	1件: Ursodeoxycholic acid	1件: D00734	1件: NR1H4 💬	1件: Bile secretion 💬	4件: 93, 94, 96, 97
1300	Ustekinumab	1件: Ustekinumab	1件: D09214	3件: IL12A, IL12B, IL23A 💬	28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬	16件: 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271
1301	Ustekinumab Dose Based on BSA and Body Weight	1件: Ustekinumab	1件: D09214	3件: IL12A, IL12B, IL23A 💬	28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬	1件: 97
1302	Ustekinumab induction	1件: Ustekinumab	1件: D09214	3件: IL12A, IL12B, IL23A 💬	28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬	1件: 97
1303	Ustekinumab IV	1件: Ustekinumab	1件: D09214	3件: IL12A, IL12B, IL23A 💬	28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬	2件: 49, 97
1304	Ustekinumab SC	1件: Ustekinumab	1件: D09214	3件: IL12A, IL12B, IL23A 💬	28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬	2件: 49, 97
1305	Usual current care	-	-	-	-	2件: 96, 97
1306	UTTR1147A	-	-	-	-	2件: 96, 97
1307	UTTR1147A, IL22-Fc, IL-22Fc	1件: Efmarodocokin alfa	1件: D11953	1件: IL22 💬	4件: Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬	2件: 96, 97
1308	UTTR1147A/RO7021610 (Active)	-	-	-	-	2件: 96, 97
1309	V565	-	-	-	-	2件: 96, 97
1310	Vaccine Vivotif + Vaccine Dukoral	2件: Recombinant Cholera Toxin B Subunit, Typhoid Vaccine Live	-	-	-	1件: 97
1311	Vaccine Vivotif + Vaccine Dukoral + oats	3件: Oat, Recombinant Cholera Toxin B Subunit, Typhoid Vaccine Live	-	-	-	1件: 97
1312	Valganciclovir	1件: Valganciclovir	1件: D02495	-	-	4件: 85, 97, 299, 331
1313	Vaminolac	-	-	-	-	1件: 97
1314	Vaminolac, komb.	-	-	-	-	1件: 97
1315	Vamorolone	1件: Vamorolone	1件: D11000	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	2件: 97, 113
1316	Vamorolone 4% suspension for oral dosing	1件: Vamorolone	1件: D11000	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	1件: 97
1317	Vancomycin	1件: Vancomycin	1件: D00212	-	-	8件: 13, 46, 70, 94, 96, 97, 296, 299
1318	Vancomycin Oral Capsule	1件: Vancomycin	1件: D00212	-	-	1件: 97
1319	Vancomycin Pre-Treat	1件: Vancomycin	1件: D00212	-	-	1件: 97
1320	Vancomycin Pre-Treatment	1件: Vancomycin	1件: D00212	-	-	1件: 97
1321	Vatelizumab	1件: Vatelizumab	-	-	-	2件: 13, 97
1322	VB-201	1件: VB-201	-	-	-	1件: 97
1323	VB-201 160mg	1件: VB-201	-	-	-	1件: 97
1324	VE202	-	-	-	-	1件: 97
1325	VEDOLIZUMAB	1件: Vedolizumab	1件: D08083	2件: ITGA4, ITGB7 💬	15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬	3件: 94, 96, 97
1326	Vedolizumab 108 mg SC	1件: Vedolizumab	1件: D08083	2件: ITGA4, ITGB7 💬	15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬	1件: 97
1327	Vedolizumab 300 mg	1件: Vedolizumab	1件: D08083	2件: ITGA4, ITGB7 💬	15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬	1件: 97
1328	Vedolizumab 300 mg IV	1件: Vedolizumab	1件: D08083	2件: ITGA4, ITGB7 💬	15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬	1件: 97
1329	Vedolizumab Injection	1件: Vedolizumab	1件: D08083	2件: ITGA4, ITGB7 💬	15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬	1件: 97
1330	Vedolizumab Intravenous (IV), Vedolizumab Subcutaneous (SC), Placebo IV	1件: Vedolizumab	1件: D08083	2件: ITGA4, ITGB7 💬	15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬	1件: 97
1331	Vedolizumab intravenous injection	1件: Vedolizumab	1件: D08083	2件: ITGA4, ITGB7 💬	15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬	2件: 96, 97
1332	Vedolizumab IV	1件: Vedolizumab	1件: D08083	2件: ITGA4, ITGB7 💬	15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬	3件: 94, 96, 97
1333	Vedolizumab IV, Placebo IV, Placebo SC	1件: Vedolizumab	1件: D08083	2件: ITGA4, ITGB7 💬	15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬	1件: 97
1334	Vedolizumab IV, Placebo SC	1件: Vedolizumab	1件: D08083	2件: ITGA4, ITGB7 💬	15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬	1件: 97
1335	Vedolizumab SC	1件: Vedolizumab	1件: D08083	2件: ITGA4, ITGB7 💬	15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬	2件: 96, 97
1336	Vedolizumab SC 108 mg	1件: Vedolizumab	1件: D08083	2件: ITGA4, ITGB7 💬	15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬	2件: 96, 97
1337	Vedolizumab subcutaneous injection	1件: Vedolizumab	1件: D08083	2件: ITGA4, ITGB7 💬	15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬	2件: 96, 97
1338	Vedolizumab, Entyvio	1件: Vedolizumab	1件: D08083	2件: ITGA4, ITGB7 💬	15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬	2件: 96, 97
1339	Vedolizumab, Ustekinumab, or Tofacitinib	3件: Tofacitinib, Ustekinumab, Vedolizumab	3件: D08083 , D09214 , D09970	9件: IL12A, IL12B, IL23A, ITGA4, ITGB7, JAK1, JAK2, JAK3, TYK2 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, Arrhythmogenic right ventricular cardiomyopathy, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, ECM-receptor interaction, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Focal adhesion, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pertussis, Primary immunodeficiency, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Yersinia infection 💬	1件: 97
1340	VEDULIZUMAB	-	-	-	-	1件: 97
1341	Vidofludimus	1件: Vidofludimus	-	-	-	5件: 13, 46, 94, 96, 97
1342	VIDOFLUDIMUS CALCIUM	2件: Calcium, Vidofludimus	-	-	-	4件: 13, 94, 96, 97
1343	Vidofludimus calcium dihydrate	2件: Calcium, Vidofludimus	-	-	-	1件: 97
1344	Vigantol	-	-	-	-	4件: 13, 65, 96, 97
1345	Vigantol Oel	-	-	-	-	3件: 13, 96, 97
1346	Vigantol Oel TM	-	-	-	-	2件: 96, 97
1347	Visilizumab	1件: Visilizumab	1件: D06314	3件: CD3D, CD3E, CD3G 💬	11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬	2件: 96, 97
1348	Visilizumab (HuM291	1件: Visilizumab	1件: D06314	3件: CD3D, CD3E, CD3G 💬	11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬	1件: 97
1349	Visilizumab (Nuvion)	1件: Visilizumab	1件: D06314	3件: CD3D, CD3E, CD3G 💬	11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬	1件: 97
1350	Visilizumab (Nuvion®	1件: Visilizumab	1件: D06314	3件: CD3D, CD3E, CD3G 💬	11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬	1件: 97
1351	Vitamin B2	1件: Riboflavin	1件: D00050	-	-	1件: 97
1352	Vitamin D	1件: Vitamin D	-	-	-	20件: 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 179, 222, 228, 235, 274, 298, 299
1353	Vitamin D drops	1件: Vitamin D	-	-	-	2件: 96, 97
1354	Vitamin D3	1件: Cholecalciferol	1件: D00188	1件: VDR 💬	5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬	12件: 6, 13, 20, 46, 49, 51, 53, 60, 65, 96, 97, 299
1355	Vitamin E	1件: Vitamin E	1件: D02331	-	-	11件: 2, 6, 13, 20, 46, 90, 96, 97, 206, 299, 317
1356	Vitamin E 800IU	1件: Vitamin E	1件: D02331	-	-	2件: 96, 97
1357	Vivotif	1件: Typhoid Vaccine Live	-	-	-	1件: 97
1358	VSL#3	-	-	-	-	4件: 96, 97, 107, 291
1359	VSL#3®	-	-	-	-	2件: 96, 97
1360	VTX002	-	-	-	-	1件: 97
1361	VTX002 is not biologic	-	-	-	-	1件: 97
1362	Water	1件: Water	1件: D00001	-	-	21件: 2, 5, 6, 13, 17, 22, 35, 46, 53, 57, 63, 65, 67, 78, 84, 96, 97, 206, 226, 278, 299
1363	Wharton Jelly Mesenchymal stem cells	-	-	-	-	1件: 97
1364	XELJANZ	1件: Tofacitinib	1件: D09970	4件: JAK1, JAK2, JAK3, TYK2 💬	37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬	4件: 46, 97, 107, 271
1365	XELJANZ -	1件: Tofacitinib	1件: D09970	4件: JAK1, JAK2, JAK3, TYK2 💬	37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬	1件: 97
1366	XELJANZ 5 mg film-coated tablets	1件: Tofacitinib	1件: D09970	4件: JAK1, JAK2, JAK3, TYK2 💬	37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬	2件: 46, 97
1367	Xeljanz 5mg film-coated tablets	1件: Tofacitinib	1件: D09970	4件: JAK1, JAK2, JAK3, TYK2 💬	37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬	1件: 97
1368	Z-206	-	-	-	-	2件: 96, 97
1369	ZEPOSIA® (ozanimod)	1件: Ozanimod	1件: D10968	5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬	3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬	1件: 97
1370	Zessly	1件: Infliximab	1件: D02598	1件: TNF 💬	67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬	2件: 96, 97
1371	Zoenasa-1:4	-	-	-	-	1件: 97